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Clostridioides difficile Infection (CDI) is a known healthcare acquired disease and 
significant source of antibiotic-associated diarrhoea (AAD),  reported to be responsible 
for up to a third of recorded instances worldwide. Most of the research conducted into 
how C. difficile causes disease is carried out in artificial laboratory media, limiting 
insight into how this pathogen responds to the environment in which it causes disease 
i.e. the large intestine. The overall aim of this study was to construct a faecal water 
model to study the transcriptome of C. difficile 630 in order to characterise the 
molecular mechanisms underpinning pathogenesis within the organism. We 
hypothesised that understanding how C. difficile functions in a more biologically 
relevant setting would uncover mechanisms at work that could not be determined with 
the use of normal laboratory media by developing an in-vitro model to determine 
growth characteristics and the transcriptional profile of C. difficile 630 and the mutant 
strains Derm, dnaK and spo0A. We have contributed significantly within this thesis to 
the current understanding of C. difficile 630 and many of the processes involved in 
pathogenesis by providing a deeper understanding of how the transcriptome of C. 
difficile 630 alters in response to faecal water highlighting that important molecular 
processes are not being picked up in studies that employ basic laboratory growth 
media. The impact of the faecal water growth environment on C. difficile is clear with 
significant expressional changes observed in sporulation, motility, virulence factors 
and an important role for regulatory sRNAs in these processes. We have therefore 
provided a more realistic indication of how this organism may respond in the presence 
of human gut constituents whilst underscoring the regulatory effect FW has on gene 
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1.1 Microbial evolution 
Microorganisms are widely believed to be amongst the earliest forms of life on Earth 
(Dodd et al., 2017). Some of the earliest forms of fossilised microorganisms have been 
found in hydrothermal vent precipitates, from the Nuvvuagittuq belt in Quebec, 
Canada. They are thought to have formed between 3.8 and 4.3 billion years ago - 
relatively soon after the formation of Earth some 4.5 billion years ago (Dodd et al., 
2017). The most common theory amongst evolutionary experts is that the last universal 
common ancestor (LUCA) to all living things was an anaerobic prokaryote that 
occupied hydrothermal vents, an environment composed primarily of H2, CO2 and iron 
(Landan and Graur, 2007; Weiss et al., 2016).  
 
Evolution has led to the development of organisms far removed from these primitive 
microorganisms that inhabited the Earth. However, the development of ribosomal 
RNA (rRNA) sequencing (Woese et al., 1990) has allowed the generation of rRNA 
phylogenetic trees that help to illustrate the relationships that link all life forms to one 
another (Figure 1.1) (Woese and Fox, 1977; Woese 1987; Woese et al., 1990). In many 
of the bacterial phylogenetic trees that have been developed, members of the firmicutes 
are placed close to the root, (and therefore closest to the LUCA core of the tree) with 
the majority of firmicutes being characterised by their low guanine-cytosine (GC) 
nucleic acid composition, Gram-positive cell wall and their ability to form endospores 
(Galperin, 2013; Martin and Sousa, 2016). The firmicutes are generally separated into 
the anaerobic Clostridia and the obligate or facultative aerobes, including the Bacilli 
(Galperin, 2013), both of which give rise to a number of important human pathogens 




Clostridioides difficile (previously Clostridium difficile (Lawson et al., 2016)). C. 
difficile is thought to have emerged approximately 1-2 million years ago but has only 
been thought of as a human pathogen for just over 40 years (Bartlett et al., 1977; He 




Figure 1.1:  Phylogenetic tree of life based on genetic sequencing of ribosomal RNA. 
Origin represents the last universal common ancestor (LUCA). Taken from Pace, 




1.2 The Genus Clostridium 
The bacterial species within the genus Clostridium are endospore-producing, low GC-
containing, Gram-positive bacteria. They are obligately anaerobic with rod shaped 
vegetative cells (Sebaihia et al., 2006; Galperin, 2013). Members of this species are 
commonly found in soil, sewage and the intestinal tracts of many animals including 
humans; and members of this genus have been found to be responsible for causing 
severe (often life-threatening) disease which can be facilitated in some cases by toxins 
such as those produced by the organisms Clostridium tetani, Clostridium botulinum 
and Clostridioides difficile. Illness caused by these organisms can range from food 
poisoning, infectious diarrhoea and enterocolitis to gas gangrene, tetanus and 
bacteraemia (Galperin, 2013; Nagahama et al., 2019). Clostridium species are a vastly 
phylogenetically varied group of organisms comprising of almost 200 described 
species, more than 100 of which are spore-forming (Elsayed & Zhang, 2004). Their 
capacity to form endospores that are resistant to heat, pH and various other chemical 
perturbations allows them to persist in harsh and often variable environments such as 
those found in the intestinal tracts of animals.  
 
Many species of Clostridium have now had their genomes sequenced and annotated 
including the pathogenic species C. perfringens (Shimizu et al., 2002), C. tetani 
(Bruggemann et al., 2003), C. difficile and C. botulinum (Sebaihia et al., 2006, 2007). 
Research has now shown that C. difficile is distinctly different to other members of the 
Clostridium genus and therefore it has been placed in a separate genus which has been 
named “Clostridioides” (Lawson et al., 2016). 16S rRNA gene sequencing has 




of the Clostridia (Yutin and Galperin, 2013). It was initially proposed to change the 
name of C. difficile to Peptoclostridium difficile but that has been disregarded in favour 
of Clostridioides difficile as this will allow the commonly used abbreviations C. 
difficile and C. diff to continue to be used both medically and commercially (Lawson 
et al., 2016).  
 
Sebaihia et al. (2006) were the first to complete the sequence and annotation of the C. 
difficile 630 genome. This particularly virulent strain was first isolated in Zurich, 
Switzerland, in 1982 from a patient with pseudomembranous colitis (PMC). It was 
found that more than 1/10th of the genome comprised of mobile genetic elements such 
as mobile introns, transposons and bacteriophage sequences (Sebaihia et al., 2006; 
Mullany et al., 2015). Determining the genomic configuration of these organisms 
allows further elucidation of the underlying mechanisms leading to virulence and the 
defence mechanisms employed by the organisms. In addition to this, genomic 
information offers a greater insight into the usefulness of several members of this 
genus in the biotechnology industry such as C. beijerinckii in the production of acetone 
and butanol from the metabolism of carbohydrates (Ezeji et al., 2003; Hemme et al., 
2010; Kalia et al., 2011).  
 
1.3 Clostridioides difficile 
 Clostridioides difficile is a particularly problematic human pathogen - a spore-
forming, rod-shaped bacillus which Gram-stains positive and displays obligately 




humans, it was first discovered in 1935 by Hall and O’Toole when it was isolated from 
the stool of healthy infants and was originally named to reflect the difficulty 
encountered when trying to grow it in the laboratory (Hall and O’Toole, 1935). 
Optimum growth is achieved on blood agar at 37 °C in an anaerobic environment 
usually made up of approximately 80% N2, 10% CO2 and 10% H2. C. difficile grows 
in cream to yellow ground-glass colonies on agar and are usually 2 mm or more in 
diameter after approximately 24 h of incubation. They also produce a distinctive horse 
stable odour (Burnham and Carroll, 2013). Two types of enterotoxins, A and B are 
produced; these toxins are the main cause of the bacterium’s pathogenicity and work 
to disrupt the host cell’s actin cytoskeleton (Di Bella et al., 2016). It wasn’t until 1977 
that it was discovered to be the cause of diarrhoea and colitis linked to use of the 
antibiotic Clindamycin (Bartlett et al., 1977). Spores are produced when the actively 
growing organism is placed in an environment it is unable to tolerate, such as extreme 
pH, temperature, salinity etc. This dormant form allows the organism to survive until 
favourable conditions are once again encountered, upon which spore germination 
occurs and active growth can continue (Kochan et al., 2018). Toxin and spore 
production by C. difficile will be discussed in greater detail in subsections 1.7 and 1.9, 
respectively.  
 
1.4 Clostridioides difficile as a human pathogen 
Clostridioides difficile infection (CDI) causes infectious bacterial diarrhoea which can 
lead to life-threatening complications such as pseudomembranous colitis (PMC), a 
condition characterised by inflammation of the colon and resulting in severe ulceration 




therapy can alter the indigenous microflora of the gut, thereby allowing spores of the 
organism to germinate; the vegetative cells then grow and produce toxins (see 
subsection 1.7. Toxin production and role in pathogenesis), which lead to illness (He 
et al., 2010). See Figure 1.2 for an overview of how C. difficile leads to disease within 
the gut. Symptoms resulting from CDI include abdominal pain, cramping, 
leucocytosis, and a fever of up to 41 °C (Bartlett, 2008). Approximately 80% of CDI 
cases occur in people over the age of 65, due to the reduction in immune function 
associated with ageing and the increasing likelihood of co-morbidities and 
polypharmacy in these individuals (Bartlett, 2009). The anoxic environment of the 
inside of the colon is the ideal setting for anaerobic organisms such as C. difficile to 
survive. Thereby, colonisation in other areas of the body including the small intestine 
is uncommon (Abt et al., 2016).  
 
CDI often starts off as simple water-dense diarrhoea, which can then progress towards 
more serious issues such as colonic inflammation and the formation of lesions within 
the colonic mucosa. At an advanced stage of the infection, pseudomembranous colitis 
and toxic megacolon, which is characterised by severe distension of the large bowel, 
can occur; both of which are indicative of CDI. In a fifth of cases of advanced disease 
patients experience very little diarrhoea and instead present with abdominal distention 
and ileus, in these cases misdiagnosis as irritable bowel syndrome (IBS) or 
inflammatory bowel disease (IBD) is common (Ramsey et al., 2002; Jackson et al., 
2016). In contrast, systemic inflammatory response syndrome (SIRS) can develop in 
many instances of CDI, leading to severe hypotension, acute renal failure, and 




development of fulminant colitis often requires total colectomy and intensive 
antibiotic therapy. However, despite these measures mortality rates remain at 
approximately 70% in these patients (Sartelli et al, 2015; Ramsay et al., 2018). It can 
be difficult to predict when or if CDI will lead to fulminant CDI requiring surgery. 
Progression can be within hours of symptom onset to weeks from initial presentation. 
Many factors are thought to be involved such as patient age, immune status, co-
morbidities, current medication and the virulence of the strain of C. difficile involved 
(Heinlen and Ballard, 2010; Asempa and Nicolau, 2017). 
 
 
Figure 1.2: Development of Clostridioides difficile infection (CDI) within the human 





1.5 Epidemiology of Clostridioides difficile infection 
The collection of epidemiological data allows clinicians and researchers to track, 
catalogue and compare pathogenic strains. This information is important as it enables 
the planning for and control of public health concerns such as an outbreak of C. difficile 
infection within a community or healthcare setting. The more that is known about the 
factors that contribute to disease outbreaks the better equipped we are to reduce the 
severity of any future events (Martin et al., 2016). It has been reported that C. difficile 
is the cause of up to 30% of all incidents of infectious diarrhoea associated with 
antibiotic consumption, with approximately half a million patients in US hospitals in 
2006 being diagnosed with the condition (Rupnik et al., 2009; Khan and Elzouki, 
2014). An increase in the number of cases of CDI across the United States, Canada 
and Europe over the last two decades has been associated with the emergence of the 
so called hypervirulent strain of C. difficile BI/NAP1/027, first identified in Quebec, 
Canada in 2005 (McDonald et al, 2005; Tillotson and Tillotson, 2011; Balsells et al., 
2019). The virulent nature of this strain has been linked to the increased production of 
the enterotoxins A and B and the additional virulence factor, binary toxin (C. difficile 
transferase (CDT)), in addition to increased resistance to the fluoroquinolones. By 
2010 this strain had spread worldwide (McDonald et al, 2005; Pépin et al., 2005; 
Clements et al., 2010). Increased surveillance within Europe including the UK and 
Northern Ireland between 2004 and 2008 identified ribotypes 027, 106 and 001 as the 
most common with deaths from the illness rising by 400% during this period within 
England and Wales (Tillotson and Tillotson, 2011). An outbreak caused by ribotype 
027 occurred at the Stoke Mandeville Hospital in 2003-2004 followed later that year 
by a second outbreak causing a total of 38 deaths. An investigation was carried out 




not following adequate infection control practices such as hand-washing and changing 
PPE often enough as they did not have the time due to a staff shortage (Commission 
for Healthcare Audit and Inspection, 2006). 
 
The spread of CDI has also been problematic in long-term healthcare facilities such as 
care homes for the elderly due to a number of factors including advanced age, immune 
compromisation and the communal nature of the living environment (Freeman et al. 
2010). A study by Khanna et al. (2012) has found that in comparison to healthcare 
acquired CDI, community acquired is more likely to occur in the younger population 
(median age of 50 years compared to 72 years in hospital acquired) and is more 
prevalent than previously thought. McDonald et al. (2007) define community acquired 
CDI as diarrhoea occurring where the patient has not been admitted to hospital in the 
preceding 12 weeks or for symptoms to occur within 48 h of admission to hospital. 
Community acquired CDI is still not as widely recognised as nosocomial CDI (Al 
Assaad et al., 2020) and this has led to a lack of screening for the disease in addition 
to the increasing use of broad-spectrum antibiotics and gastric reflux medications such 
as proton-pump inhibitors and H2 receptor blockers in general practice – all of which 
are known to contribute to the development of the disease. The elevation in gastric pH 
caused by gastric reflux medications reduces the bactericidal effect of the gastric acid, 
increasing the chance of C. difficile colonisation (Kyne et al in 1998; Kwok et al., 
2012; Janarthanan et al., 2012; Freedberg and Abrams, 2013).  
 
Rates of deaths related to C. difficile infection have been declining within Northern 




and Research Agency (NISRA) show that in 2017 there was a total of 52 deaths where 
C. difficile was mentioned on the death certificate compared to 191 in 2008 (Figure 
1.3).  This decline can most likely be to attributed to increased awareness amongst 
both healthcare staff and the public in addition to the implementation of more robust 
infection control mechanisms (see subsection 1.11. Treatment and prevention for 





Figure 1.3: Mortality rates for deaths involving Clostridioides difficile registered in 
Northern Ireland between 2008 and 2017 (Northern Ireland Statistics and Research 





























1.6 Typing methods 
The identification of Clostridia by established procedures such as biochemical testing 
and conventional culture is still costly and time-consuming (Humphries and Linscott, 
2015). Moreover, many commercially available methods for the identification of 
anaerobic microorganisms phenotypically, have proven unsuccessful in correctly 
recognising Clostridium species (Planche et al., 2008; Bagdasarian et al., 2015; 
Humphries and Linscott, 2015). These drawbacks have led to the development of 
newer, more efficient molecular techniques to aid in the identification of many 
important species within the genus (Song, 2005; Lindstrom and Korkeala, 2006). A 
number of typing techniques have been developed to allow identification and 
differentiation between isolates, thereby allowing the epidemiology of C. difficile to 
be investigated and monitored (Curry, 2010; Griffiths et al., 2010). Conventional 
typing methods that were formerly based on phenotypic properties of the various 
strains have since been superseded by more advanced molecular methods such as PCR 
ribotyping.  
 
1.6.1 PCR Ribotyping  
PCR ribotyping is based on identification of disparities in the nucleotide sequence of 
the 16S and 23S ribosomal RNA (rRNA) intergenic spacer regions of C. difficile 
strains and was first described by Gurtler et al. (1991). The amplified nucleic acid is 
cut using restriction enzymes producing bands of varying patterns. These bands are 
compared to reference libraries in order to identify the “ribotype”. Compared to many 




spacer regions making it particularly suitable to PCR ribotyping (Sadeghifard et al., 
2006).  
 
1.6.2 Restriction endonuclease analysis (REA) 
REA uses whole-genome DNA, which has been digested by the restriction enzyme 
HindIII. Agarose gel electrophoresis is then used to separate the resultant restriction 
fragments. The advantages of this technique are that it is stable and highly 
discriminatory. However, the process can be technically arduous and the data is not 
easily compared between different laboratories (Huber et al., 2013).  
 
1.6.3 Surface layer protein A-encoding gene (slpA) typing  
It has been found that the surface layer protein (SlpA) varies amongst C. difficile 
strains, therefore sequencing of the variable region of the slpA gene has been utilised 
as a method for typing C. difficile (Mori and Takahashi, 2018). This method is not 
widely used as it has been shown that isolates with the same ribotype or MLST type 
have different slpA types (Dingle et al., 2013).  
 
1.6.4 Arbitrarily primed PCR AP-PCR 
An alternative molecular technique known as arbitrarily primed PCR (AP-PCR) 
identifies polymorphisms within the C. difficile genome without the requirement of 
advanced knowledge of the target nucleotide sequence (Brazier, 2001). Although rapid 





C. difficile toxin production can also be used to distinguish between the strains, this 
technique is known as toxinotyping and utilises restriction fragment length 
polymorphism (RFLP)-PCR, by identifying sequence variations in the pathogenicity 
locus (PaLoc) (a region of the genome containing toxins A and B genes), which are 
compared to a reference strain. Each strain is categorised into one of 27 toxinotypes, 
with C. difficile 630 classed as toxinotype 0. Toxinotyping is useful for identifying the 
toxin status of the strain (i.e. which combination of A, B and/or binary toxin the strain 
possesses) although it does not have the same discriminatory power as other methods 
such as PCR ribotyping (Rupnik et al., 2001; Huber et al., 2013; Singh et al., 2017).  
 
1.6.6 Multilocus sequence typing (MLST) 
Multilocus sequence typing (MLST), enables the rapid genotyping of C. difficile 
isolates through the amplification of reference genes such as those that code for 
triosephosphate isomerase (tpi), recombinase A (recA) and adenylate kinase (adk) 
(Griffiths et al., 2010). MLST is useful for population studies but is relatively 
expensive compared to PCR ribotyping (Kuijper et al., 2009).  
 
1.6.7 Multilocus variable-number tandem-repeat analysis (MLVA) 
Capillary electrophoresis is utilised in MLVA to resolve fragments by size, and 
determine the number of repeat sequences that are present. MLVA has more 




relationships between strains. This technique can generate digital data that can be 
shared between labs, however it can be expensive to carryout (Hardy et al., 2012). 
 
1.6.8 Pulsed-field gel electrophoresis (PFGE) 
PFGE separates large fragments of whole-genome DNA which have been cut using 
restriction enzymes such as SmaI or SacII. Some of the first forms of this method were 
unreliable due to DNA degradation and difficulties with lysing spores. However, 
modifications to the electrophoresis method have led to the ability of this technique to 
achieve 100% typeability. One major disadvantage of this method is speed, with 
complete analysis taking several days to obtain (Huber et al., 2013).  
 
1.6.9 Whole genome sequencing 
Whole genome sequencing (WGS) allows detailed characterisation of pathogens in all 
kinds of samples using next generation sequencing (NGS) technology (Sabat et al., 
2017). Advantages include exact strain determination allowing tailored patient 
management and accurate pathogen surveillance data, which can be quickly shared 
between laboratories for monitoring purposes (Rossen et al., 2018). WGS is being 
increasingly used in clinical microbiology laboratories however a number of issues 
prevent it from replacing routine microbiology at the present time including 
turnaround time, cost and complications of downstream data analysis, which must be 
performed by highly trained personnel (Rossen et al., 2018). Although many methods 




discriminatory and affordable method available (Brazier, 2001; Griffiths et al., 2010; 
Huber et al., 2013).   
 
1.7 Toxin production and role in pathogenesis 
Whilst numerous virulence factors are known to be involved in C. difficile 
pathogenesis and colonisation, the development of CDI is strongly associated with the 
presence of two toxins - Toxin A (TcdA) and toxin B (TcdB) (Awad et al., 2014; 
Chandrasekaran and Lacy, 2017). Toxin A is a 308 kDa enterotoxin and toxin B is a 
270 kDa cytotoxin, both exert tissue damaging ability, attacking the colonic mucosa 
through binding to membrane receptors and entering the mucosal cells by receptor-
mediated endocytosis (Genth et al., 2008). A 19.6 kb chromosomal region known as 
the pathogenicity locus (PaLoc) (Figure 1.4) is where the Toxin A (tcdA) and B (tcdB) 
genes are located within the C. difficile genome. The PaLoc consists of tcdA and tcdB, 
as well as three other genes involved in the regulation of toxin gene expression – tcdR, 
tcdE, and tcdC. TcdE encodes a holin-like protein, a type of bacteriophage protein 
involved in the release of progeny phages from the host organism. Consequently, TcdE 
is also thought to play a role in the release of TcdA and TcdB through the cell wall 
(Tan et al., 2001; Govind and Dupuy, 2012). TcdR encodes an extra-cytoplasmic 
sigma factor which works to positively regulate itself in addition to tcdA and tcdB 
(Mani and Dupuy 2001; Mani et al., 2002). Sigma factors help to facilitate the binding 
of RNA polymerase to promoter regions within the genome to enable the initiation of 
transcription of specific genes in response to the cellular environment. They join 
together with RNA polymerase to form the RNA polymerase holoenzyme (Paget, 




behaving mainly as an anti-sigma factor by inhibiting transcriptional activity (Dawson, 
et al., 2009; Carter et al., 2011).   
 
Researchers have uncovered strains of C. difficile where regions of the PaLoc are 
missing, these are referred to as A-B+ or A-B- strains (Dawson, et al., 2009). One such 
study by Stabler et al. (2006) looked at 75 strains of C. difficile and identified four 
separate clusters – a hypervirulent (HY), toxin-variable (A-B+), and two 
human/animal clades (HA1 and HA2). Differences separating the clades included 
variations in toxin, antibiotic resistance, adhesion, motility and metabolism gene 
sequences (Stabler et al., 2006). It has also been noted that non-toxin producing C. 
difficile strains can acquire the PaLoc from toxigenic strains by horizontal gene 
transfer, thereby transforming non-toxigenic strains into toxin expressers (Brouwer et 
al., 2013). This gene transfer is mediated through the integration of active conjugative 
transposons (CTns) into the genome. CTns are genetic elements that are present in 
toxin producing strains such as C. difficile 630 and have been shown to be capable of 
inserting themselves into other strains such as the non-toxin producing C. difficile 
CD37 (Brouwer et al., 2013). The conjugative transposon CTn2 was shown to be able 
to transfer the PaLoc from C. difficile 630 to strain CD37 and more importantly this 
strain was shown to be able to express the acquired toxins (Brouwer et al., 2013). As 
there have been proposals to use non-toxigenic strains as a means of treatment of CDI 





A binary toxin known as CDT has been found in a number of strains, initially in the 
CD196 strain (non-epidemic PCR-ribotype 027 strain) isolated from a patient in Paris 
in 1985 (Popoff et al., 1988). CDT is made up of an enzymatic component and a 
binding component (CdtA and CdtB, respectively) and works mainly to cause 
disruption of the host epithelial cell cytoskeleton, with CdtA modifying actin (by 
enabling ADP-ribosylation of monomeric actin causing depolymerisation of actin 
filaments) and CdtB helping CdtA cross into the cytosol. CdtB essentially acts as a 
transport element by facilitating the translocation of CdtA into the target cells (Davies 
et al., 2011). It is also believed that the presence of the binary toxin and an associated 
regulatory protein (CdtR) may heighten the toxicity of TcdA and TcdB by positively 
regulating the expression of tcdA and tcdB, thereby increasing virulence of the 
organism and leading to more severe disease (Denève, et al., 2009).  
 
The virulence of the epidemic C. difficile ribotype 027 strain is thought to be due to a 
frameshift mutation present in the tcdC coding sequence at nucleotide position 117, 
with this polymorphism leading to the production of a truncated protein (Wolf et al., 
2009). Consequently, TcdC is unable to carry out its role in negatively regulating toxin 
production, causing increased expression of toxin A and B by approximately 16-fold 
and 23-fold, respectively, when compared to C. difficile isolates that lack the 
frameshift mutation (Warny et al., 2005). Although toxins are the main virulence 
factors, others do exist such as adhesins including GroEL, cell wall proteins and 
flagellar proteins (Hennequin et al., 2003; Sebaihia et al., 2006; Janoir et al., 2007; 






Figure 1.4: Two main C. difficile toxin loci. (A) The PaLoc encodes toxin A (tcdA) 
and toxin B (tcdB), as well as three accessory proteins (tcdR, tcdE and tcdC). Dashed 
arrow represents a partial pseudogene found downstream of tcdE. (B) CdtLoc encodes 
two binary toxin genes (cdtA and ctdB) and one accessory gene (ctdR) (Elliot et al., 
2017). 
 
1.8 Non-toxin virulence factors 
Bacterial organisms such as C. difficile are able to survive during exposure to stressful 
conditions in a number of ways. One such mechanism is the heat shock response in 
which molecular chaperones, called heat shock proteins (HSPs), are responsible for 
conferring protection to the organism by refolding damaged proteins. HSPs respond 
not only to heat but also to many other stressful situations such as nutrient deprivation 
or antimicrobial therapy. Numerous molecular chaperones have been identified 
including HSP60, HSP70, HSP90 and HSP100 amongst many others. The molecular 
chaperone GroEL, a member of the HSP60 family, has been shown to be involved in 
the binding of cells to the epithelial lining of the intestine and is found at increased 





levels at the surface of C. difficile cells heat-shocked at 48 °C (Hennequin et al., 2001a; 
2001b; 2003; Jain et al., 2011; Jain et al., 2017). Many environmental conditions can 
lead to an increase in gene expression and protein abundance of this particular 
molecular chaperone such as increased temperature and osmolarity, iron deficiency, 
and antibiotics (Hennequin et al., 2001a; Emerson et al., 2008). A member of the 
HSP70 family of proteins, DnaK, has been shown to assist in the folding of non-native 
polypeptides (i.e. polypeptides that are not in their correct 3D form and therefore lack 
function (Liberek et al., 2008). Jain et al. (2017) found that biofilm formation is 
increased in a dnaK ClosTron disruption mutant when compared to the wildtype, 
suggesting that this increase results from the response of the organism to stress and is 
used as a protection mechanism. Furthermore, the dnaK mutant did not form 
observable flagella thereby rendering the organism immotile (Jain, 2010; Jain et al., 
2017; Alotaibi, 2017).  
 
These observations, in addition to the dnaK mutant’s sensitivity to elevated 
temperatures and impaired growth rates, indicate that the organism is, physiologically, 
in a state of heat stress due to lack of DnaK protein function (Jain et al., 2017). These 
significant observations in the dnaK disruption mutant highlight the importance of 








1.9 Sporulation  
C. difficile is a spore-forming organism meaning that it possesses the ability to produce 
a highly resistant, infectious form of itself when under stressful conditions. Spores 
allow spore-producing organisms to survive when placed in an environment not 
normally conducive to sustained growth until they again find themselves in more 
favourable conditions when the vegetative form can proliferate. Sporulation is one of 
the main reasons C. difficile is so highly contagious, as spores are easily transmitted 
from the faeces of both humans and animals (Brown and Wilson, 2018).  Sporulation 
takes place in the gut, subsequently spores are shed in the faeces – transmission from 
person to person then ensues via the faecal-oral route (Freeman et al., 2010; Zhu et al., 
2018).  
 
Sporulation in C. difficile involves a complicated sequence of stages ultimately leading 
to the development of metabolically inactive spores from vegetative cells (Figure 1.5) 
(Zhu et al., 2018). In C. difficile, the resilient nature of the spores can be accredited to 
their structure, consisting of an inner core containing the complete genome, which is 
surrounded by the cortex (made-up of modified cross-linked peptidoglycans), this is 
further encircled by the spore-coat composed of a thick coat of peptidoglycan and a 
final outer layer known as the exosporium – a loose-fitting structure composed of a 
basal layer and an outer layer of hair-like projections (Paredes-Sabja et al., 2014). The 
exosporium is not present in all spore-forming bacteria but is found in many clostridial 
species including the pathogens C. botulinum and C. difficile amongst others (Paredes-
Sabja et al., 2014). Sporulation in C. difficile typically follows 4 main stages. Stage 0 




asymmetric septation occurs creating a smaller compartment (SC) and a larger mother 
cell (MC). Stage II is where the SC becomes the forespore and is engulfed by the MC 
in a phagocytic manner. In Stage III construction of the spore cortex and coat begins 
followed by Stage IV when the MC breaks down to discharge the mature spore into 
the immediate environment (Fimlaid and Shen, 2015; Zhu et al., 2018).  
 
 
Figure 1.5: Key morphogenic stages of sporulation and spore structure in C. difficile. 
MC, mother cell compartment; SC: smaller compartment; FS: forespore compartment; 
MS: mature spore (Zhu et al., 2018). 
 
At the transcriptional level, C. difficile sporulation is initiated by five orphan histidine 
kinases (a histidine kinase gene not directly associated with a response regulator gene), 
CD1352, CD1492, CD1579, CD1949 and CD2492, when environmental signals 
indicate that growth is no longer feasible. This leads to phosphorylation of the master 




σE, σG, and σK (Underwood et al., 2009; Steiner et al., 2011; Fimlaid and Shen, 
2015). CD1579 is the only kinase known to phosphorylate Spo0A directly 
(Underwood et al., 2009). The σ factors σF, σE, σG, and σK have been found to control 
transcriptional regulation in a compartment-specific manner. Factors σE and σK are 
specific to the mother cell (MC), whereas σF and σG are specific to the developing 
forespore (FS) (Pereira et al., 2013; Al-Hinai et al., 2014; Fimlaid and Shen, 2015; 
Zhu et al., 2018). In contrast to B. subtilis the activity of σE in C. difficile is not fully 
dependent on σF. In addition to this, σG does not require σE for activation, and σK 
does not require σG for activation. Moreover, the post-translational activation of σG 
was found to be dependent on σF (Fimlaid et al., 2013). These four sigma factors 
interact with a number of sporulation-associated genes in a controlled systematic 
fashion usually in response to either internal or external (e.g. bile acids, nutrient 
deprivation etc.) stimuli; see Figure 1.6 for a detailed overview of the proposed 








Figure 1.6: Proposed sporulation cascade for Clostridioides difficile 630 developed by Pettit et al. (2014). Solid arrows in the putative regulatory 
cascade of C. difficile are confirmed interactions. Dotted arrows are uncharacterized or proposed interactions. Vertical blue bars are in vitro 
confirmed Spo0A binding sites. Genes in grey represent tentative homologs of B. subtilis sporulation genes. Green colours specify genes 






1.10 Diagnosis of C. difficile Infection (CDI) 
Testing for CDI is carried out when a patient presents with typical symptoms 
associated with CDI such as abdominal pain and diarrhoea and has recently undergone 
a course of antibiotic therapy (short or long term). In some cases, they may also have 
a fever of up to 41 °C (Bartlett and Gerding, 2008). The main determinants of a suitable 
test for the diagnosis of CDI are cost, availability, specificity, sensitivity and 
turnaround time (Gilligan, 2015). There are five tests that are currently accepted as 
being clinically useful. They are glutamate dehydrogenase (GDH) detection, enzyme 
immunoassay (EIA) for detection of toxins A/B, toxigenic culture (TC), cytotoxin 
neutralization (CTN) and nucleic acid amplification tests (NAATs) (Avila et al., 
2016). The glutamate dehydrogenase (GDH) test uses antibodies to detect the presence 
of the GDH enzyme and is a highly sensitive immunoassay method that allows reliable 
exclusion of C. difficile if the result is negative (Fenner et al., 2008). If a positive GDH 
result is produced, further testing is recommended, such as EIA toxin test for the 
presence of toxins A/B (Crobach et al., 2016; Martinez-Melendez et al., 2017). EIA 
tests tend to produce a signal on detection of the toxin, usually this is a colour change 
and can be measured spectrophotometrically via a microplate reader (Crobach et al., 
2016). Unfortunately, most commercially available toxin EIAs lack sensitivity, at 60-
95% sensitive, which is why nucleic acid amplification tests (NAAT) are more often 
used to confirm the results of the EIA. NAATs can provide a more rapid diagnosis 
compared to GDH and EIA. However, false positives can occur due to the sensitivity 
of the NAATs and their inability to distinguish between active toxins as they are only 
able to detect the presence of the toxin gene. This can lead to over-diagnosis and 





Real-time polymerase chain reaction (RT-qPCR) can be utilised in order to rapidly 
confirm the presence of specific genes such as the tcdB gene which controls production 
of toxin B or the gene which negatively regulates toxin A and B production, tcdC. This 
method can also be used to detect nucleotide deletions in the tcdC gene, known to 
cause over-production of toxins A and B in the B1/NAP1/027 C. difficile strain 
(discussed in subsection 1.7. Toxin production and role in pathogenesis), providing 
the added benefit of being able to distinguish between strain types (Crobach et al., 
2016). Various algorithms of these methods are often employed in different 
laboratories making the diagnosis of CDI far from straight forward (Ignatius et al., 
2019). In the United Kingdom the guidelines issued by the Department of Health 
recommend a combination of two tests should be carried out to confirm the diagnosis 
of CDI. It is recommended that the initial test is a NAAT or GDH followed by a toxin 
EIA test (ARHAI, 2012). Although guidelines should be followed as closely as 
possible for all clinical decision making, the choice of testing algorithm used is 
ultimately laboratory and patient specific (Avila et al., 2016). 
 
1.11 Treatment and prevention 
First-line treatment for C. difficile infection (CDI) should involve the immediate 
removal of the initiating antimicrobial agent and replacement with antibiotics that are 
less commonly associated with the development of CDI such as the imidazoles (e.g. 
metronidazole), glycopeptides (e.g. vancomycin) and macrolides (e.g. fidaxomicin) 
(Bauer et al., 2009; Debast et al., 2014). In mild cases, withdrawal of the causative 
antimicrobial can often lead to cure of CDI without further treatment (NHS, 2018). 





the development of vancomycin resistant Enterococci (VRE) and thus, it is reserved 
for patients who are intolerant to, or fail to respond to metronidazole (Tacconelli and 
Cataldo, 2008; Faron et al., 2016). Metronidazole and vancomycin have been in use 
as therapeutic agents against CDI for over three decades and are still first-line options. 
Current therapeutic targets for CDI include DNA, RNA, protein synthesis and cell wall 
integrity amongst others (see Figure 1.7 for overview). In addition to antimicrobial 
therapy, treatment plans should include the implementation of strict infection control 
policy and the correction of fluid loss and electrolyte imbalance (Leffler and Lamont, 
2015; Gerdling et al., 2016; Napolitano and Edmiston, 2017). 
 
Under stressful conditions such as heat, antibiotics or nutrient limitation, spores are 
produced that are highly resistant to various environmental conditions including 
antibiotics and many sterilisation methods such as industrial cleaners, making them 
difficult to eradicate (Sorg and Sonenshein, 2008; Kochan et al., 2018). The antibiotics 
required to eradicate the vegetative bacteria do not kill the spores and often contribute 
to recurrence by disrupting the normal gut flora even further. In the event that 
antibiotic therapy fails or exacerbates the infection, a colectomy may be carried out in 
severe, complicated or fulminant cases of CDI as a very last resort to reduce the 
potential for progression of the colitis and development of toxic megacolon (Bauer et 
al., 2009; Surawicz et al., 2013; Gerdling et al., 2016).  
 
In instances of recurrent CDI, oral vancomycin or fidaxomicin is recommended. 





treatment option in recurrent cases, whereby the normal gut microflora is restored with 
faecal matter from a donor, administered most commonly via nasoduodenal tube. FMT 
has been shown to be not only safe but also successful in treating recurrent CDI in 
over 90% of patients (Kassam et al., 2013). Widespread use of FMT is held back by 
the need for regulated stool banks to safely distribute donor stool to hospitals when 
required. Dedicated centres are essential to ensure safety and traceability of donations 
in addition to monitoring of outcomes for quality control purposes (Cammarota et al., 
2019). As rates of antimicrobial resistance continue to rise this particular form of 
therapy is likely to become more widely utilised in the treatment of intestinal 
infections.  
 
Strict implementation of measures to prevent the spread of C. difficile are imperative 
in the healthcare environment. The use of gloves and gowns on entry to the room of a 
patient and stringent hand washing by all hospital staff and visitors as well as 
sterilisation of surfaces and equipment are all important measures in the prevention of 
transmission (Gerding et al., 2008, Hsu et al., 2010). Public Health England strongly 
recommend immediate isolation of suspected CDI cases, alongside prompt treatment 
with appropriate antibiotics to prevent further spread and reduce the possibility of an 
outbreak from occurring (Wilcox, 2013; Peng et al., 2018). A potentially complicating 
factor is the asymptomatic carriage of C. difficile which is thought to affect between 7 
- 15% of the population (Galdys et al., 2014) and which is transient in nature, making 
strict infection control practices all the more important (Furuya-Kanamori et al., 
2015). However, careful antibiotic prescribing practices are by far the most important 





remain that haven’t been implicated in the development of CDI, but those most 
commonly associated are amoxicillin, fluoroquinolones, cephalosporins, ampicillin 
and clindamycin. Reducing the number and duration of prescriptions of these 
antibiotics (antibiotic stewardship) remains key to controlling the development and 
spread of this pathogen (Surawicz et al., 2013).  
 
The use of probiotics has been investigated extensively in recent years with widely 
varying outcomes. Many studies have concluded that there is a benefit to the use of 
probiotics including various lactobacilli species such as L. acidophilus, L. casei, L. 
rhamnosus and L. plantarum in the prevention of CDI (Gao et al., 2010; Johnston et 
al., 2012; Maziade et al., 2015; Ratsep et al., 2017) while others have determined that 
probiotics are ineffective as a prophylactic against CDI (Pochapin, 2000; Wullt et al., 
2003; Pozzoni et al., 2012; Allen et al., 2013). For example, the use of Bacteroides 
fragilis as a barrier to C. difficile colonisation was demonstrated by Deng et al. (2018) 
who showed in a mouse model that pathogen colonisation was decreased, and gut 
barrier integrity and function was increased, thereby preventing epithelial stress and 
destruction. The study of novel targets for the treatment of C. difficile has become 











Figure 1.7: Bacterial targets for Clostridioides difficile infection diagnosis and 
treatment. Text in red - indicated targets for diagnostics. Text in green - indicated 








1.12 Gene editing – ClosTron technology 
A number of mutant strains of C. difficile have been developed in order to further 
elucidate the role of a gene of particular interest within the C. difficile genome. Tools 
have been created that disrupt the expression of the gene of interest, allowing 
subsequent investigation of the effects of this on the organism as a whole. The 
ClosTron system developed by Heap et al. (2007) is one such technique utilised in 
functional genomics studies. The ClosTron is a universal gene knockout system which 
employs mobile group II introns from the ltrB gene of Lactococcus lactis (L1.LtrB) to 
modify double-stranded DNA thereby leading to permanent disruption of the target 
gene (Heap et al., 2007; Joseph et al., 2018). Group II introns are designed by the 
modification of nucleotides within the group II intron encoding region allowing the 
intron to be targeted to any section of the genome. The re-targeted intron is designed 
using an online re-targeting algorithm on www.clostron.com (Kuehne and Minton, 
2012). Mutants that contain the successfully inserted intron can be screened on 
erythromycin-containing media as the C. difficile 630 Δerm strain used to generate the 
mutant is erythromycin resistant. The Δerm strain was generated through continuous 
subculturing of C. difficile 630 daily for 30 days (Hussain et al. 2005). An antibiotic 
resistance marker (ermB - which codes for erythromycin resistance) is incorporated 
into the design of the group II introns to allow for positive selection of mutants. ErmB 
is inactivated by the insertion of a group I intron (phage td). When the group II intron 
inserts successfully into the chromosome and is transcribed, the group I intron is able 
to self-splice out as it is now in the correct orientation to do so, thereby reactivating 
the erythromycin resistance gene and allowing for positive selection of intron-
containing ClosTron disruption mutants on erythromycin-supplemented media (Heap 





Examples of mutants generated by this mechanism include the spo0A disruption 
mutant created by Heap et al. (2007) and further investigated by Underwood et al. in 
2009 in order to study the role of Spo0A in C. difficile. A dnaK disruption mutant was 
developed at Ulster University by Jain (2010) which has also been used within this 
project to support the investigation of the role of molecular chaperones within C. 
difficile (further discussed in Chapter 4).  
 
1.13 Clostridioides difficile model systems 
Relevant model systems for the growth and investigation of C. difficile are vitally 
important in further developing our understanding of how this pathogen behaves 
beyond the limited laboratory environment. Many systems have been used in recent 
years including animal models using mainly rodents such as hamsters, rats and mice. 
In addition, a number of in vitro models have been developed in an attempt to more 
closely mimic the human gut environment, such as faecal emulsions in batch and 
continuous culture systems (Best et al., 2012).  
 
Animal models for use in the study of C. difficile have been in existence for over three 
decades. Animals used have included mice, rats, rabbits, guinea pigs and even 
zebrafish embryos. However, the animal most commonly used tends to be the hamster, 
due to the similarities found in their susceptibility to infection following antimicrobial 
therapy to that of humans (Sambol et al., 2001; Razaq et al., 2007). A number of 
studies of C. difficile in the hamster model helped lead to the association of C. difficile 





1977; Bartlett et al., 1978; Borriello et al., 1987). Nevertheless, there are many 
drawbacks to the use of animals namely the obvious genetic, physical and 
pathophysiological differences as well as ethical issues that exist around the use of 
animals in research studies.   
 
In vitro models that utilise human faecal matter in various forms (Gill et al., 2007; Gill 
et al., 2010; Brown et al., 2012) possess a number of advantages, including the ability 
to finely control these systems, which is more difficult in animal models, and the 
elimination of ethical issues. Continuous culture systems have been used that allow 
investigation over longer time periods. Studies involving continuous culture have 
looked at areas of C. difficile development such as colonisation resistance, external 
environmental impacts and the effect of antibiotics such as the triple stage gut model 
developed by McFarlane et al. in 1998. This system uses three anaerobic vessels 
controlled to maintain pH and flow rate of growth media introduction, which allows 
the controlled exploration of cells, toxins, spores, microflora and antimicrobial effects 
(McFarlane et al., 1998). However, there are a number of disadvantages associated 
with continuous culture methods as they require intensive effort and expense to 
maintain.  
 
Batch culture models using faecal material within closed systems offer significant 
advantages such as the ability to include more replicates within the experimental 
design allowing result analysis to be more robust and thereby reliable. They also allow 
for a shorter experimental duration whilst still offering a more reflective gut 





was used in the investigation of bacteriophage (Bacteriophage ФCD27 induced from 
C. difficile strain NCTC 12727 using mitomycin C) as a treatment option for C. 
difficile infection. It was found that there was a significant decrease in recoverable C. 
difficile after prophylactic phage administration (Meader et al., 2010). Due to the 
success of previous studies using batch culture faecal models and the aforementioned 



















1.14 AIMS OF THIS STUDY 
There is a current lack of knowledge around how C. difficile causes disease in the real-
world (i.e. outside of the artificial environment of laboratory growth media) due to 
limitations on the use of human and animal models. This study aims to develop an in-
vitro model to further characterise the molecular processes underpinning pathogenesis 
in C. difficile 630. We hypothesis that understanding how C. difficile functions in a 
more biologically relevant setting will uncover mechanisms at work that cannot be 
determined with the use of normal laboratory media. In order to do this we will: 
 
• Develop an in-vitro model to determine the growth characteristics of C. 
difficile 630 and demonstrate by RNAseq and RT-qPCR analysis significantly 
differentially expressed genes in order to further characterise pathogenesis in 
C. difficile strain 630.  
• Further study the transcriptome of the C. difficile 630 mutant strains dnaK and 
spo0A grown in faecal water compared to the parental strain Derm in order to 
investigate a number of known virulence-associated genes in this organism.  
• Experimentally verify the presence and expression of sRNAs in C. difficile 
630 in normal growth media and in biologically relevant growth conditions 





























2.1 Chemicals and glassware 
All chemicals and reagents of Analar grade or better were purchased from Sigma-
Aldrich (Poole, UK) unless stated. Brain Heart Infusion (BHI) agar and broth, and 
yeast extract were purchased from Oxoid (Basingstoke, UK). All molecular biology 
reagents were purchased from Invitrogen (Renfrewshire, UK) save for qPCR reagents, 
which were obtained from Roche Diagnostics (Hertfordshire, UK) and random 
primers, which were obtained from Promega (Southampton, UK). Lysing Matrix A 
tubes were from MP Biomedicals (Cambridge, UK). All apparatus was cleaned with 
1% Virkon (Antec Intl Ltd., UK) and 2 % Decon (Decon Labs Ltd., UK) before use. 
Used glassware was left in 1% Virkon overnight and then soaked in 2% Decon for 30 
minutes. 
 
2.2 Growth of bacterial strains  
Clostridium difficile 630, ∆erm, dnaK and spo0A were grown in either BHIS, 
BHIS/PBS or BHIS/FW media under anaerobic conditions. The anaerobic cabinet 
used was a Don Whitley MACS MG500 (Don Whitley Scientific Ltd, Yorkshire, UK). 
The anaerobic conditions within the cabinet were 80% N2, 10% CO2 and 10% H2 at 
37 °C.  The growth media consisted of either 1X BHIS (brain heart infusion broth 
(Oxoid, Hampshire, UK) supplemented with 5g/L-1 yeast extract (Sigma-Aldrich, 
Dorset, UK) and 1g/L-1 L-cysteine (Sigma-Aldrich, Dorset, UK)) broth, 50% 2X 
BHIS/50% faecal water or 50% 2X BHIS/50% PBS. A starter culture was prepared by 
inoculating 20 ml of 50% 2X BHIS broth/50% PBS in a glass universal bottle with a 
single colony of freshly grown culture from BHIS agar; this was grown overnight and 





at 650 nm (D650) by transferring 800 μl or 80 μl of sample to a cuvette (depending on 
type of cuvette used), and measuring D650 using a Pharmacia Novaspec II 
spectrophotometer. The samples of culture taken for measurement were diluted 1 in 4 
once an attenuance of 0.2 was reached to maintain accuracy of measurements. All 
equipment used including the BHIS media, H20 and PBS were autoclaved before use. 
The faecal water was filter-sterilised through a 0.22 μm filter. Un-inoculated BHIS 
media and BHIS/faecal water mix were used as references. Cells were collected from 
all cultures at early, mid and late-log phase of growth at attenuance (D) values of 
approximately 0.2, 0.6, and 1.2 respectively by transferring 1 ml of each sample to an 
Eppendorf tube and centrifuging at 13,000 x g for 5 min at room temperature. The 
supernatant was discarded and the cell pellets were placed briefly in liquid nitrogen 
and immediately transferred to -80 °C. Strain identity was confirmed by genotyping. 
End-point PCR was carried out using the primers dnakF/dnakR, 4140/4620, 
4140/5880, 5880/7020, EBS universal/dnaKR, spo0AF/spo0AR, EBS 
universal/spo0R (Table 2.2) on genomic DNA extracted from each strain.  
 
2.2.1 Calculation of growth rate constant (ƙ) and doubling time (Td) 
The growth rate constant (ƙ) and doubling time (Td) was calculated for each strain 
grown in each growth medium from attenuance collected hourly at 650 nm (D650). 
Exponential growth measurements from the linear part of the growth curve were used 







Formula used to calculate growth rate constant (ƙ): 
ƙ = (log10N – log10N0) × 2.303/ (t-t0)  
N0 = OD650nm at time 0hr 
N = OD650nm at the time of exponential growth ending  
t = time of exponential growth ending (hr) 
t0 = time at inoculation (0hr)  
Formula used to calculate doubling time (Td):  
Td = 0.693 / ƙ  
 
2.3 Faecal water preparation  
This study was not subject to review by the Ulster University ethics committee as no 
intervention took place involving the volunteers who provided the samples although 
written consent was obtained. The samples were obtained for the express purpose of 
preparing growth media. Faecal samples were provided by two male donors aged 
between 38-42; neither had taken any antibiotics in the three months prior to 
collection. The samples, once collected, were stored at 4 °C for a maximum of 2 h and 
processed as described in Gill et al., 2010. This involved weighing the stool sample 
before mixing with ice cold 0.01 M PBS at a ratio of 1:1 w/v. This mixture was then 
homogenised in a Seward 600 stomacher for 2 minutes (x 2). Following 





rotor of a Beckman L8-M centrifuge. Supernatants were recovered and subject to filter 
sterilisation on ice using a 0.22 μm filter; aliquots were stored at -80 °C.  
 
2.4 RNA extraction and quality control 
RNA was extracted using the RNeasy® Mini kit from Qiagen (Crawley, UK). C. 
difficile 630 cell pellets containing approximately 2x108 cfu were resuspended in 200 
μl of lysozyme (Sigma-Aldrich, Dorset, UK) in TE buffer (15mg/ml) and 20 μl of 
Proteinase K (Qiagen, Crawley, UK). The pellets were incubated at room temperature 
for 15 min before being transferred to a lysing matrix A tube (MP Biomedicals, 
Cambridge, UK). The tube was placed in a FastPrep™ FP120 instrument at speed 
setting 5.5 for 30 s to homogenise the cells. Following this, 700 μl of buffer RLT and 
7 μl of β-mercaptoethanol were added. The samples were vortexed vigorously and 
incubated at room temperature for 20 min. The lysate was then transferred to a 1.5 ml 
Eppendorf tube, making sure to avoid the beads at the bottom of the lysing matrix tube, 
and centrifuged at 14,000 rpm for 2 min. The supernatant was then transferred to a 
new 1.5 ml Eppendorf tube and 500 μl of 100% ethanol was added and the contents 
pipetted up and down to mix. Of this lysate 700 μl was transferred to an RNeasy Mini 
spin column placed in a 2 ml collection tube and centrifuged for 30 s at 14,000 rpm. 
The flow-through was discarded. This step was repeated for the remainder of the lysate 
and the flow-through again discarded. The collection tube was also discarded and 
replaced with a new one. To the spin column 350 μl of buffer RW1 was added and the 
tube inverted by hand to wash inside of the spin column. The sample was centrifuged 
for 30 s at 14,000 rpm, the flow-through was again discarded and the collection tube 





dissolving 1500 units of DNase I (Qiagen, Crawley, UK) in 550 μl of RNase-free 
water) was added to 70 μl of buffer RDD and gently mixed. The total of 80 μl of the 
DNase I incubation mix was then added directly onto the spin column membrane and 
incubated for 30 min at room temperature to allow digestion of contaminating DNA. 
Following digestion, 350 μl of buffer RW1 was then added to the spin column and 
incubated for 5 min at room temperature. The column was then centrifuged at 14,000 
rpm for 30 s and the flow-through discarded. The spin column was then placed into a 
new 2 ml collection tube and 500 μl of buffer RPE was added to the column and 
centrifuged at 13,000 x g for 2 min to wash the membrane. The collection tube was 
replaced and another 500 μl of buffer RPE was added to the column followed by 
further centrifugation at 13,000 x g for 2 min to ensure removal of residual ethanol 
from the spin column membrane; the flow-through was discarded. The column was 
placed inside a clean collection tube and without addition of buffer was centrifuged 
again for 5 min. The spin column was then placed in a new 1.5 ml collection tube and 
30 μl of RNase-free water was added to the column and incubated at room temperature 
for 5 min, the tube was then centrifuged at 13,000 x g for 1 min in order to elute the 
RNA.  
 
An in-solution DNase digestion step was carried out to ensure no genomic DNA 
contamination remained in the RNA sample; this was performed by mixing ≤ 87.5 μl 
of eluted RNA with 10 μl of DNase I stock solution and 10 μl of buffer RDD in a 1.5 
ml Eppendorf tube. RNase-free water was added to the sample to make a final volume 
of 100 μl. The mixture was incubated for 20 min at room temperature; following this 





250 μl aliquot of 100% ethanol was then added and the contents of the sample 
transferred to an RNeasy Mini spin column placed in a 2 ml collection tube. The RNA 
was then purified as described previously and checked for DNA contamination by 
PCR followed by electrophoresis and imaging under UV light. A Nanpdrop™ 1000 
spectrophotometer (Thermo Scientific) was used to quantify the amount of RNA in 
the samples.  
 
2.5 Bioanalysis of RNA samples  
The quality of the RNA was further assessed with the use of an Agilent 2100 
Bioanalyzer (Agilent, USA), which uses electrophoresis to generate a ratio of the 23S 
and 16S ribosomal bands represented by the RNA integrity number (RIN). An 
algorithm produces a number between 1 and 10 to indicate the level of degradation 
present. Ten represents the most intact RNA sample possible, with 1 therefore 
representing the most degraded sample. An RNA 6000 Nano Assay kit (Agilent, USA) 
was used to prepare the RNA samples for analysis as per manufacturer’s instructions, 
which included the following method. A 550 µl aliquot of RNA 6000 Nano Gel Matrix 
was added to a spin filter which was then centrifuged at 1,500 x g for 10 min. The 
filtered gel product was aliquoted into 65 µl aliquots in RNase-free microcentrifuge 
tubes and stored for up to 4 weeks at 4 °C. Following this, the Gel-Dye mix was 
prepared by initially allowing the RNA 6000 Nano dye concentrate to equilibrate to 
room temperature for 30 min. The RNA 6000 Nano dye concentrate was vortexed for 
10 s then centrifuged at 13,000 x g for 10 s before the addition of 1 µl of dye into the 
65 µl aliquot of filtered gel (previously prepared). The sample was then vortexed again 





chip was placed onto the chip priming station and 9 µl of gel-dye mix was loaded onto 
the appropriate well. The chip priming station was closed and the plunger pressed until 
held by the clip; the clip was released after 30 s. A 9 µl aliquot of gel-dye mix was 
added to the other indicated wells and the remaining gel-dye mix was discarded. A 5 
µl  aliquot of the RNA 6000 Nano marker was loaded onto the chip in the well labelled 
with a ladder symbol and in the 12 sample wells. A 6 µl aliquot was added to all unused 
wells. The RNA 6000 Nano ladder and the RNA samples were heated to 70 °C for 2 
min before use. Following this a 1 µl aliquot of RNA 6000 Nano ladder was added to 
the well marked with the ladder symbol and 1 µl of RNA sample (diluted to between 
50-500 ng/µl) was loaded into the sample wells. One µl of RNA 6000 Nano marker 
was added to each unused sample well (there must be no empty wells on the chip). The 
chip was placed onto the adapter of the IKA vortex mixer (Agilent, USA) and vortexed 
at 2,400 rpm for 1 min. The electrodes were decontaminated prior to use by loading a 
spare chip with 350 µl of RNaseZAP and placing this into the analyser and closing the 
lid for 1 min, this chip was removed and 350 µl of RNAse-free water was loaded onto 
another spare chip and placed inside the analyser with the lid closed for 10 s and then 
removed. The chip containing the RNA samples was then transferred to the 
bioanalyser within 5 min and run using the Agilent 2100 Bioanalyzer software as 
described in the manufacturer’s instructions. An electropherogram was produced for 








2.6 Transcriptome sequencing 
RNA sequencing (RNAseq) and bioinformatics was carried out by Deepseq 
(University of Nottingham, UK). RNA samples were transported to Deepseq on dry 
ice, and once received, total RNA quality was again measured using the Agilent RNA 
6000 Nano Kit (Agilent Technologies, USA) on the Agilent 2100 Bioanalyzer. The 
concentration of the RNA was calculated using the Qubit RNA BR assay kit (Life 
Technologies, USA). The Ribo-Zero rRNA Removal Kit (Gram-Positive Bacteria) 
(Illumina, Cambridge, UK) was used for rRNA depletion. NEBNext Ultra Directional 
RNA library prep kit for Illumina (NEB, UK) was used to prepare Illumina stranded 
whole transcriptome sequencing libraries. The normal procedure for preparation of 
Ribosome Depleted RNA was followed apart from precipitation of samples with 1 µl 
(20 ng/µl) glycogen and 1/10th vol. 3M sodium acetate after second strand synthesis. 
Pellets were washed once with 80% ethanol, then 70% ethanol and following air-
drying, 58 µl of water was used to resuspend pellets. The standard Ribosome Depleted 
RNA protocol was recommenced for the outstanding steps, except libraries were size 
selected using Agencourt AMPure XP beads at a 1.5 x ratio to preserve the smaller 
sized fraction (~ 150bp). Barcoded multiplex libraries were generated using the NEB 
Next Multiplex Oligos for Illumina kit (Primer set 1) (NEB, UK). Library quality 
control was carried out using the Bioanalyser HS kit (Agilent Technologies, USA) and 
libraries were measured using qPCR (Kapa Biosystems, UK). Libraries were 
combined at desired concentrations, denatured and loaded for sequencing according to 
the manufacturer’s protocol. Three runs of sequencing was performed on the Illumina 





The sequencing reads were mapped onto the annotated C. difficile 630 reference 
genome (http://www.ncbi.nlm.nih.gov/nuccore/115249003) with suitable alignment 
software for differential gene expression analysis. The aligned files were combed for 
tag counts per location mapped or normalised tag counts (RPKMs) and differential 
gene expression analysis. The DeepSeq Filtering Pipeline for Read Mapping was 
utilised to filter reads with low sequencing score, as well as to reads aligned to adaptor 
sequences. Reads from the sequencer were quality control checked using FASTQC, 
then cropped and filtered for low quality bases and adaptor sequences, before being 
quality control checked again. The bwa mapping tool (http://bio-bwa.sourceforge.net/) 
was used to chart reads that passed the filter onto the reference genome in the context 
of known gene exon coordinates. Read alignments were saved in a BAM formatted 
alignment file (named *.bam), and companion BAM index file (named *.bam.bai). 
Both primary and unique read alignments were filtered further by their mapping 
quality score (MAPQ). For gene expression, MAPQ20 uniquely aligned reads were 
used to create counts per gene using 'htseq-count', which concludes the number of 
uniquely aligned reads per gene (http://www-
huber.embl.de/users/anders/HTSeq/doc/count.html), which were then used as the 
input for the DESeq program (Anders and Huber, 2010a; Anders and Huber, 2010b). 
DESeq models the distribution of the counts data in each sample and then compares 
the distributions to determine differentially expressed genes, with significantly 
differentially expressed genes having an adjusted p-value < 0.05. A single analytical 
approach is used by the program and DESeq analyses the variance of the biological 





The data generated was deposited in NCBI’s Gene Expression Omnibus (Edgar et al., 
2002) repository (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE11242), 
accession number: GSE112422. 
 
2.7 Transcriptome data analysis 
Transcriptome sequence data was obtained from DeepSeq as a summary MS Excel file 
containing a list of genes with cognate base mean values for BHI medium (BHI, base 
mean A) and faecal water medium (FW, base mean B) growth conditions, in addition 
to p value, p-adjusted value and the ratio of FW/BHI base mean values, sorted by p-
adjusted (padj) value from low to high. Some 1218 genes had padj < 0.05. The base 
mean values for these genes were used to calculate log2 values for each FW/BHI ratio, 
from which the absolute fold-change for each gene was determined. Subsequent 
analysis was performed using this master list of 1218 differentially expressed (DE) 
genes with pdaj < 0.05 and FC > 1.5. The NCBI C. difficile 630 genome 
(http://www.ncbi.nlm.nih.gov/nuccore/115249003) was used for addition of the C. 
difficile 630 locus annotations (Sebaihia et al., 2006; Monot et al., 2011), in addition 
to protein name and Subtilist functional category (Moszer et al., 2002; Lechat et al., 
2008). This process was carried out as described previously (Ternan et al., 2012; 
Ternan et al., 2014) using the NCBI CDD database, BioCyc pathway tools and 
MetaCyc metabolic pathways software (Marchler-Bauer et al., 2015; Caspi et al., 
2016; Karp et al., 2016) in conjunction with literature searching to determine a 







2.8 Reverse transcription 
cDNA was prepared from the extracted RNA samples by adding 50 ng of random 
hexamer primer (Promega, WI, USA) to a 0.2 ml Eppendorf tube, to this 500 ng of 
RNA sample was added. The volume was made to 12 μl with RNase-free water and 
the mixture was incubated at 70 °C for 10 min. To each tube 4 μl of 5 X First strand 
buffer, 2 μl of 0.1 M DTT, 1 μl of 10 mM dNTP mix and 1 μl of RNaseOUT™ 
Ribonuclease Inhibitor (Invitrogen, Paisley, UK) was added. The tubes were incubated 
at 42 °C for 2 min. Following incubation, 200 U of SuperScript™ Reverse 
Transcriptase (1 μl) was added followed by a further incubation step at 42 °C for 50 
min. A final incubation at 70 °C for 15 min was completed in order to inactivate the 
SuperScript™ enzyme. An “RT negative” control was also prepared alongside the 
other samples, which contained all of the reaction solutions apart from the reverse 
transcriptase enzyme.  
 
2.9 Primer design and validation  
The primers used in this thesis (unless otherwise stated) were designed using 
Primer3Plus software version 2 (Untergasser and Nijveen, 2007). In order to save on 
time, money and the chance of variability the melting temperatures were kept as 
similar as possible as this would allow more than one gene to be analysed on a plate 
at once. Other parameters taken into consideration included the amplicon size, which 
for qPCR purposes was less than 250 bp, the GC content was kept to between 20-80% 
and the primer size between 18-27 bp. Primers were reconstituted in nuclease-free 
water to a concentration of 30 pmol/µl and stored at -80°C in 100 µl aliquots. End-





difficile 630. Only those primer pairs that produced a clear bright band on gel 
electrophoresis imaged under UV light were used in subsequent experiments.  
 
2.10 Polymerase chain reaction (PCR) 
PCR was carried out using a TGradient Thermocycler (Biometra, Goetigen, 
Germany). All PCR reagents were purchased from Invitrogen (Paisley, UK). The PCR 
master mix was made up of 100 μl of 10 X PCR buffer, 30 μl of 1.5 mM MgCl2, 2 μl 
of each dNTP from a 100 mM stock and made up to 1 ml with 827 μl of millipore 
water; 96.5 μl of this master mix was added to a 0.2 ml PCR tube, to this 1.5 U of Taq 
polymerase, 1 mM of forward and 1 mM of reverse primer (30 pmol/μl) and 1 μl of 
template was added to make up a total 100 µl PCR reaction. The PCR cycling 
conditions used were as follows: an initial denaturation stage for 5 min at 95 °C 
followed by 30 cycles of 95 °C for 30 s, an annealing stage at 57 °C for 30 s and 
extension at 72 °C for 30 s with a final extension at 72 °C for 5 min.  
 
2.11 DNA extraction – Fast DNA Spin Kit method  
DNA was extracted using the Fast DNA Spin Kit (MP Biomedicals, Leicester, UK) 
from C. difficile 630 pellets containing approximately 4 x 108 cells. The cell pellet was 
resuspended in CLS-TC buffer by vortexing for 10 s. The suspension was then 
transferred to a lysing matrix A tube (MP Biomedicals, Leicester, UK) and a 
FastPrep®FP120 cell disrupter (Qbiogene, France) was used to homogenize the 
solution for 40 s at a speed setting of 6.0. Following this, the sample was centrifuged 





carefully removed and added to a 15 ml polypropylene tube with an equal volume of 
binding matrix. Gentle agitation was performed for 5 min on a Luckham 802 
Suspension Mixer rotator at speed setting 7. A 700 µl aliquot of the suspension was 
transferred to a SPINFilter™ placed inside a catch tube and centrifuged  for 1 min at 
13,000 × g. The catch tube was emptied and this step was repeated until all sample had 
been transferred through the matrix by centrifugation. The binding matrix remaining 
on top of the SPINFilter was resuspended in 500 µl of SEWS-M wash solution by 
pipetting up and down several times. The SPINFilter was placed inside a clean catch 
tube and centrifuged for 1 min at 13,000 x g. The catch tube was emptied and the 
SPINFilter was centrifuged again for a further 2 min at 13,000 x g in an effort to 
remove any remaining ethanol from the wash step. The SPINFilter was placed inside 
a sterile 1.5 ml Eppendorf tube and 100 µl of DES (DNase-free water) was used to 
gently resuspend the binding matrix. This was followed by incubation at 55 °C for 5 
min on a Grant microtube block thermostat (UK); the Eppendorf containing the 
SPINFilter was centrifuged for 1 min at 13,000 × g. Following this, the SPINFilter 
was discarded and the extracted DNA was quantified using the Nanodrop™ 1000 
Spectrophotometer (Thermo Fisher Scientific, Loughborough, UK). A 5 μl aliquot of 
the extracted DNA was electrophoresed on a 1.5% agarose gel to visualise and the 
DNA was stored in 10 μl aliquots at -20 °C. 
 
2.12 DNA extraction – Chelex method  
C. difficile 630 pellets containing approximately 4 x 108 cells were washed by 
resuspension in 1 ml of ice-cold PBS followed by centrifugation at 13,000 x g for 10 





supernatant was discarded and the cell pellet was again resuspended in 1 ml of ice-
cold PBS by vortexing for 5-10 s. Following this, the suspension was centrifuged again 
at 13,000 x g for 10 min at 4 °C and the supernatant was discarded; this step was 
performed a further time. A 5% w/v Chelex (Sigma-Aldrich, UK) solution was 
prepared in PBS and the cell pellet was resuspended in 300 µl of this solution. A Grant 
microtube block thermostat (UK) was used to incubate the solution at 100 °C for 15 
min. Centrifugation was carried out at 13,000 x g for 10 min at 4 °C to separate the 
now in-solution DNA from the Chelex resin. The supernatant was transferred to a 
sterile Eppendorf and stored at -20 °C.  
 
2.13 Gel electrophoresis 
A 1.5% agarose gel was prepared using molecular biology grade agarose (Qbiogene, 
Quebec, Canada) and 1X TBE buffer (Invitrogen, Paisley, UK). Ethidium Bromide 
(Sigma-Aldrich, Dorset, UK) was added to the gel (4 μl/100 ml gel) to enable 
visualisation of the nucleic acid under UV light. A sample of 8 μl was mixed with 2 μl 
of loading dye (Sigma-Aldrich, Dorset, UK) and loaded into the gel. Four μl of 100 
base pair ladder (Invitrogen, Paisley, UK) was loaded as a reference to allow the 
product size to be estimated. The gel was electrophoresed at 100 v for 20 min and 
imaged using the Gel Doc™ EZ imaging system (Bio-Rad, Hertfordshire, UK). 
 
2.14 RT-qPCR 
All quantitative PCR (qPCR) was carried out using the LightCycler480 instrument 





dilution (1, 1:5, 1:25, 1:125, 1:625, 1:3125, and 1:15125) of the pooled cDNA samples 
with nuclease-free water. Each reaction well contained 5 µl of Master SYBER Green 
I (Roche Diagnostics, UK), 1 µl of forward primer, 1 µl of reverse primer (at a 
concentration of 10 µM), 2 µl of nuclease free H2O, and 1 µl of template. A 10 µl 
aliquot of reaction mix was added to each well on the 96-well plate in triplicate. A 1 
in 10 dilution of each cDNA sample was used for the target run templates. The 
programme conditions used for the qPCR were: an initial denaturation stage of 95 °C 
for 5 min followed by 40 cycles of 95 °C for 10 s, 57 °C for 10 s and 72 °C for 10 s. 
A melting curve was performed once the programme had finished and a report was 
generated to allow for subsequent analysis of the data. The Minimum Information for 
publication of Quantitative real-time PCR Experiments (MIQE) guidelines published 
by Bustin et al. in 2009 were followed when designing and carrying out all of the RT-
qPCR experiments described in this thesis.  
 
2.15 RT-qPCR data analysis 
The LC480 instrument software (version 1.5) was used in combination with SYBR 
Green I detection (Roche Diagnostics) to generate a Cq value for each sample using 
the ‘second derivative maximum’ method. Each Cq value corresponds to the point at 
which the level of fluorescence in the sample crosses the threshold of background 
fluorescence, which is inversely proportional to the amount of nucleic acid present in 
the sample. This Cq value was used to analyse the data to determine expression levels. 
Cq values were transferred to Excel and initially the arithmetic mean of the technical 
replicates was determined. This value was then log transformed to relative quantities 





pair i.e. the mean of the technical replicates minus the y-intercept value was calculated 
and then divided by the slope of the standard curve, this number was then back-
transformed to produce the RQ value. This method ensured the PCR efficiencies were 
calculated accurately for each gene and no assumptions were made. All target gene 
RQs were normalised against the geometric mean of three reference gene RQs by 
dividing the former by the later to produce the normalised relative quantity (NRQ) 
value. The untreated control samples (BHIS/PBS) were used as a calibrator and 
corrected to 1 with all experimental samples (BHIS/FW) expressed as a relative 
expression ratio to the calibrator for each gene. It is the geometric mean of the 
biological replicate calibrator normalised relative quantity (CNRQ) values that are 
reported.  
 
2.16 PCR clean-up 
The PCR products were cleaned up for sequencing using the Wizard SV Gel and PCR 
Clean-up System (Promega, USA). Firstly, an equal volume of Membrane Binding 
Solution was added to the PCR product and then transferred to an SV minicoloumn 
placed inside a collection tube. This solution was incubated at room temperature for 1 
min followed by centrifugation at 13,000 x g for 1 min. The flow-through was 
discarded at this point and the minicolumn reinserted into the collection tube. The 
product was then washed by adding 700 μl of Membrane Wash Solution to the 
minicolumn and centrifuging at 13,000 x g for 1 min, the flow-through was again 
discarded and the minicolumn reinserted into the collection tube. This step was 
repeated with 500 μl of Membrane Wash Solution, followed by centrifugation at 





of the column assembly for 1 min with lid open to allow evaporation of any residual 
ethanol. The minicolumn was then transferred to a clean 1.5 ml microcentrifuge tube 
and 50 μl of nuclease-free water was added to the minicolumn. The column assembly 
was incubated at room temp for 1 min followed by centrifugation at 13,000 x g for 1 
min to elute the PCR product. The mincolumn was then discarded and the elution was 
stored at -20 °C until needed.  
 
2.17 DNA sequencing  
The samples were prepared for sequencing using BigDye Terminator version 3.1 
Cycle sequencing kit using the following protocol: For each sequencing reaction, the 
following components were added to a sterile 0.2 ml tube: 1 μl of ready-to-use ready 
reaction mix, 2 μl 5X sequencing buffer, 1 μl of primer at a concentration of 3.2 pmol/ 
μl (forward and reverse primers were used individually in separate reactions), and 1- 
5 μl of purified PCR product depending on amplicon size. The reaction was made up 
to a final volume of 20 μl with sterile deionised water. The reaction mixture was then 
PCR amplified on a Biometra Tpersonal Thermocycler using the following 
parameters: an initial denaturation at 96 °C for 1 min followed by 25 cycles of 
denaturation at 96 °C for 10 s, an annealing stage at 50 °C for 5 s and extension at 60 
°C for 4 min.  
 
2.18 Purification of sequencing products by gel filtration 
The products were purified using Performa DTR Gel Filtration columns (Edge Bio, 





DTR Gel Filtration column by centrifuging at 900 rpm for 3 min. The column was 
then transferred to a labelled 1.5 ml tube and the sequencing reaction was added drop-
wise avoiding contact with the gel. The sample was incubated at room temperature for 
1 min to allow absorption of the BigDye by gel. The sequencing product was then 
collected by centrifuging for 1 min at 900 rpm. The elute was retained and the column 
discarded. A master mix was prepared for precipitation of the DNA containing 64 μl 
of 95% ethanol and 16 μl of dH2O. To each sample 80 μl of the master mix was added. 
The samples were incubated overnight at -20 °C and then centrifuged at 13,000 x g for 
20 min. The supernatant was aspirated using suction and 100 μl of 80% ethanol was 
added to each sample followed by incubation at room temperature for 5 min. The 
samples were centrifuged at 13,000 x g for 10 min at 4 °C and the supernatants were 
aspirated before being placed on a heat block at 65 °C for 5 min to allow evaporation 
of residual ethanol. All samples were then prepared for sequencing on the ABI PRISM 
3100 genetic analyser (Applied Biosystems, Foster City, CA) by adding 20 μl of 
formamide to each reaction mixture to stabilise the DNA strands. The samples were 
incubated at 95 °C for 5 min and then transferred directly onto ice for 3 min followed 
by brief centrifugation. The samples were then loaded onto a 96 well plate before being 
placed into the analyser. The DNA sequences were analysed using Chromas software. 
 
2.19 Endospore staining 
Liquid bacterial culture was collected at each timepoint and 40 µl was pipetted onto a 
labelled clean glass slide and allowed to air dry. The bacterial smears were then heat 
fixed by passing through a flame several times. A Bibby HC502 hot plate was set to 





placed on top of the beaker and covered with 1.5% malachite green stain for 5 min. 
Malachite green stain was continually applied throughout this time in order to prevent 
drying of the sample. Following this, excess malachite green stain was removed and 
the slides were rinsed with deionised water. The slides were then flooded with a 
counterstain of 1% safranin for 30 s. Slides were again rinsed with deionised water 
and blotted with bibulous paper and viewed under 100 X oil immersion using a Nikon 
Eclipse E400 microscope equipped with DS-5M-L1 Digital Sight Camera and NIS-
Elements Basic Research 3.2 software. Spores were counted from 10 separate fields 
of view per slide.  
 
2.20 Gram’s staining 
Liquid bacterial culture was collected at each timepoint and 40 µl was pipetted onto a 
labelled clean glass slide and allowed to air dry. The bacterial smears were then heat 
fixed by passing through a flame several times. A primary stain of 0.1% crystal violet 
was applied in excess for 30 s then washed away with deionised water. Following this, 
Gram’s iodine was applied for 30 s and then washed away with deionised water. The 
slides were washed with 95% alcohol for 10 s and then rinsed with deionised water. A 
counterstain of 1% carbol fuschin was applied for 1 min. Slides were again rinsed with 
deionised water and blotted with bibulous paper and viewed under 100 X oil 
immersion using a Nikon Eclipse E400 microscope equipped with DS-5M-L1 Digital 
Sight Camera and NIS-Elements Basic Research 3.2 software. 100 cells were 






Table 2.1: Primers used in this study.  
 





rho CD3487 Transcription 
termination 
factor Rho 
rho-F CATCAAGCAATAAATCATCTC 153 57 Metcalf et 
al, 2010 
rho-R CTGGTTCTAGGATGGATGATG 
rrs rrs 16S ribosomal 
RNA 
rrs-F GGGAGACTTGAGTGCAGGAG 120 57 Denève et 
al, 2008 
rrs-R GTGCCTCAGCGTCAGTTACAGT 






146 57 Denève et 
al, 2008 
gyrA-R ATCCCCATCAACAGAACCAA 






196 57 Metcalf et 
al, 2010 
adk-R CCTAAGGCTGCGACAATATC 






151 57 Metcalf et 
al, 2010 
rpsJ-R GTCTTAGGTGTTGGATTAGC 






116 57 This study 
groES-R CCTTATCTCCCACTGTCAATTCC 
groEL CD0194 60 kDa 
chaperone 
groEL-F TTGCTGGAGGAGTAGCTGTTG  143 57 This study 
groEL-R AAAAGCAGTTCCTCCACCAG 
fliC CD0239 Flagellin 
subunit 
fliC-F TGATGATGCTGCTGGACTTG 119 57 This study 
fliC-R ACGAACCTTCTGCTGTTTGTAC 
fliD CD0237 Flagellar cap 
protein 
fliD-F AGCTGGACAAATTGCCAGTG 114 57 This study 
fliD-R CCTTGGTCATCAGTTACATCAGC 




129 57 This study 
tcdA-R ATGGCTGGGTTAAGGTGTTG 
spoVB CD3498 Stage 5 
sporulation 
protein B 
spoVB-F ATTCAGGGAATGGGAAAACC 161 57 This study 
spoVB-R TTAATCATGGCTGCCACAAA 








CD1194 Stag  III 
sporulation 
protein AC 
















dnaK-F CTACAGCTGGTAACAATAGATTAGGT 210 57 Jain et al., 
2010 
dnaK-R CTGTAGCAGTTATGAAAGGTAAGTT 
dnaJ CD2460 Chaperone 
protein 
dnaJ-F ATTTGGCGGTCAAGGCTTTG 112 57 This study 
dnaJ-R ACGTTGAGGCCCTCTTCTTC 
tig CD3306 Trigger factor tig-F GCTGAAGGAATTGAAGCAACAG 112 57 This study 
tig-R TGTCGGCATCTCTTAAAGAAGC 
grpE CD2462 Heat shock 
protein  
grpE-F GACTTCAAGCCGAATATGCAAAC 138 57 This study 
grpE-R CACATGCATCTAAGGCTCTTTCC 
tcdB CD0660 Toxin B tcdB-F GAGAAGGGCATAATGAGAACGG 137 57 This study 
tcdB-R TGCATGACACCATCTTCACC 
tpi (1) CD3172  Triosphosphate 
isomerase 
tpi-F AAAGAAGCTACTAAGGGTACAAA 227 57 Lemèe et 
al., 2004 
tpi-R CATAATATTGGGTCTATTCCTAC 
tpi (2) CD3172 Triosphosphate 
isomerase 
tpi-F GCAGGAAACTGGAAAATGCATAA  488 55 Lemèe et 
al., 2004 
tpi-R CAGATTGGCTCATATGCAACAAC 
rpoA CD0098 RNA 
polymerase 
subunit A 
rpo0A-F GGATGATATGATGAAGGTTAGAAACCT 81 57 O’Connor 
et al., 2006 
rpo0A-R CCCAATCCAAGTTCTTCTAGTTTTTG 
gluD CD0179 Glutamate 
dehydrogenase 







Table 2.2: Primers used in genotyping of C. difficile strains. See Chapter 4, Table 4.2 













Primer Sequence (5′→3′) Target Annealing 
temp (°C) 
Reference 
4140-F TAAGAGTGTGTTGATAGTGC Erm leader peptide and erm1 (B) 57 Hussain et al., 2005  
4620-R TCAATAGAGCGTTACCTGTTTAC Erm leader peptide and erm1 (B) 57 Hussain et al., 2005  
5880-F CGACTATGTTTGCTTACTTGAC ORF298 and erm2 (B) 57 Hussain et al., 2005 
5880-R GTCAAGTAAGCAAACATAGTCG Erm leader peptide, erm1 (B), ORF3 
and ORF 298 
57 Hussain et al., 2005 
7020-R TCAATAGAGCGTTACCTGTTTAC ORF298 and erm2 (B) 57 Hussain et al., 2005 
EBS 
Universal 
CGAAATTAGAAACTTGCGTTCAGTAAA  Screening mutant 57 Heap et al., 2007 
dnaK-F CTACAGCTGGTAACAACAATAGATTAG  dnaK gene 57 Jain et al., 2017 
dnaK-R CTGTAGCAGTTATGAAAGGTAAGTT  dnaK gene 57 Jain et al., 2017 
spo0A-F TTAGGCATAGCTAAGGATGGA  spo0A gene 57 Heap et al., 2007 





 Table 2.3: sRNA primers used in this study. All primers were designed to perform 
optimally with an annealing temperature of 57 °C. 








































































CHAPTER 3: TRANSCRIPTOMIC ANALYSIS OF 
CLOSTRIDIOIDES DIFFICILE 630 GROWN IN A 




















Clostridioides difficile is a Gram-positive spore forming anaerobe and widely regarded 
as a chief cause of nosocomial infections (Rupnik et al., 2009; Burke and Lamont, 
2014). The development of disease from C. difficile infection is most likely to occur 
when the patient is receiving a course of broad spectrum antibiotics for an unrelated 
bacterial infection, this leads to a disturbance in the patient’s natural microflora 
permitting growth of the pathogen and disease development (Jarrad et al., 2015; 
Czepiel et al., 2019). Although it is well known that the gut microflora is affected by 
antibiotic consumption which can more readily lead to the establishment of C. difficile 
infection (CDI), how this process actually occurs is only just beginning to be 
elucidated. Changes in the colonic environment that can lead to the development of 
CDI have been linked to both dietary and microflora compositional fluctuations 
(Moore et al., 2015; Samarkos et al., 2018). There have been a number of model 
systems described in the literature for the study of C. difficile pathogenesis, however 
those which involve human participants are limited to prospective or retrospective 
testing for the interpretation of C. difficile strain types (Best et al., 2012). It could 
therefore be said that there are few studies in the literature currently that have 
developed experimental systems to study C. difficile virulence with direct relevance to 
the human gut environment. Faecal water (FW) however, which is the aqueous 
component of human faeces, offers a means of studying the relationship between the 
contents of the colon and the presence of C. difficile and thereby link the presence of 
this pathogen with gut health (Rafter  et al., 1987; Eid et al., 2015; Pearson et al., 2009; 
Daniela et al., 2014; Verbeke et al., 2015; Windey et al., 2015). Due to the availability 
of unbound, soluble components such as, fatty acids, short-chain fatty acids, amino 




challenge agent in a variety of gut health investigations (Boyd et al., 2006; Monleón 
et al., 2009; Gill et al., 2010; Brown et al., 2012; Claesson et al., 2012; Nowak et al., 
2014). These components are likely to play an important role in the composition and 
function of the human gut microbiome therefore we have combined FW with ordinary 
BHIS growth media as a way of simulating the human colonic setting and allowing 
subsequent biologically appropriate modelling of C. difficile.  
 
Using RNA sequencing (RNAseq) we will harness next-generation sequencing 
technology to assess the presence and quantity of RNA in our samples at the point of 
cell harvest (Wang et al., 2009; Chu and Corey, 2012). RNAseq has been developed 
to allow analysis of the cellular transcriptome of a given sample with comparison to a 
control.  RNAseq can identify total RNA as well as mRNA, small RNA, and tRNA 
transcripts (Maher et al., 2009; Ingolia et al., 2012; Stark et al., 2019). Before the 
introduction of RNAseq gene expression studies relied heavily on hybridization-based 
microarrays which were prone to issues such as cross-hybridization artifacts, 
unreliable detection of low abundance transcripts as well as the requirement for prior 
knowledge of the sequence of interest (Draghici et al., 2006; Kukurba and 
Montgomery, 2015). In addition to RNAseq we will use RT-qPCR to assess a selection 









3.2 AIMS AND OBJECTIVES 
This study aims to utilise a unique in vitro technique to demonstrate by RNAseq and 
RT-qPCR analysis which genes are significantly differentially expressed in the faecal 
water media in order to further characterise pathogenesis in C. difficile 630.  
 
The main objectives for this chapter are: 
• Design an in vitro model for investigation of the growth of C. difficile 630 in 
an environment more analogous to the human intestine.  
• Extract high quality and quantity RNA to ensure the reliability of all 
downstream applications.  
• Use RNAseq to establish the transcript status of the cells at the point of cell 
collection (late-log phase). 
• Confirm RNAseq results with the use of carefully designed and executed RT-













3.3.1 Growth of Clostridioides difficile 630 
In order to study the growth of C. difficile 630 in a more biologically replicative 
environment, the organism was grown in three separate mediums i.e. BHIS, 
BHIS/faecal water (FW) (50/50 v/v), BHIS/PBS (50/50 v/v). Attenuance (650 nm) 
was measured in triplicate over a time period of seven hours. Statistical analysis 
showed that the presence of FW in the media was not detrimental to growth of C. 




Figure 3.1: Growth (D650 nm) of Clostridioides difficile 630 in BHIS containing 50% 
faecal water, BHIS containing 50% PBS, and standard BHIS made with deionized 
H2O.  Data presented are means of three independent biological replicates and error 
bars represent the standard deviation of the mean. 
 





















3.3.2 RNA extraction and QC 
RNA was extracted from cell pellets of C. difficile 630 grown at 37 °C as described 
above. The RNA extraction method used (described in Chapter 2) was modified 
slightly from the RNeasy® Mini kit (Qiagen, UK) manufacturer’s instructions to 
increase RNA quality and yield. Changes to the protocol included incubation of the 
sample in lysing buffer for 20 minutes to help break open the Gram-positive cells. An 
extra spin step was performed (without the addition of buffer) in order to remove 
residual ethanol and buffers from the final RNA elute. The resultant RNA was 
visualised by gel electrophoresis (Figure 3.3) and the yield and quality determined 
through Nanodrop spectrophotometry (Table 3.1). PCR was carried out using the 
extracted RNA as template with tpi primers to ensure no gDNA contamination was 
present (data not shown) - this is an especially important step before reverse 
transcription of the RNA as the presence of genomic DNA in RT samples will lead to 
false positive results. The RNA was further analysed using the Agilent 2100 
Bioanalyzer. The Bioanalysis showed that the RNA was of high quality (RIN > 9.0) 
and free of degradation and residual contaminants such as buffers and salts from the 
extraction process (Table 3.1 and Figure 3.2). This was a fundamental step prior to 









Table 3.1: Bioanalysis of RNA extraction from Clostridioides difficile 630 grown in 
BHIS containing 50% faecal water (FW), BHIS containing 50% PBS and standard 
BHIS made with deionized H2O. Three biological replicates were assessed for each 






A260/280 A260/230 RIN 
FW Rep 1 1966.8 2.18 2.50 9.1 
FW Rep 2 2213.1 2.18 2.48 9.3 
FW Rep 3 2254.7 2.17 2.49 8.6 
PBS Rep 1 2097.4 2.18 2.54 9.5 
PBS Rep 2 1835.8 2.18 2.38 9.3 
PBS Rep 3 1888.3 2.18 2.51 9.6 
H2O Rep 1 1998.5 2.18 2.43 9.3 
H2O Rep 2 1504.8 2.18 2.48 9.3 












Figure 3.2a: Representative chromatogram generated from the bioanalysis of RNA 
extracted from Clostridioides difficile 630 grown to late-log phase at 37 °C in BHIS 
broth. RIN of 9.6.  
 
 
Figure 3.2b: Representative gel image generated from the bioanalysis of RNA 










Figure 3.3: Gel electrophoresis image of RNA extracted from Clostridioides difficile 
630. Lane 1: 100 bp molecular weight marker; Lanes 2-4: RNA extracted from 




3.3.3 cDNA synthesis and validation 
cDNA was synthesised successfully from the extracted RNA (Figure 3.4), in order to 
determine the presence of cDNA and absence of gDNA contamination within the 
samples PCR was performed for each reaction. Figure 3.4 shows that an amplicon 
corresponding to the tpi primer pair is present. The negative RT controls, which were 
set up alongside the cDNA samples and contain all of the reagents apart from the 













Figure 3.4: Gel electrophoresis image of cDNA synthesised using reverse 
transcriptase and amplified by PCR using tpi primers with a product size of 488 bp. 
Each RT product has a control containing no reverse transcriptase enzyme. (A) Lane 
1: 100 bp molecular weight marker. Lane 2: FW rep 1 cDNA; Lane 3: FW rep 1 -RT; 
Lane 4: PBS rep 1 cDNA; Lane 5: PBS rep 1 -RT; Lane 6: BHIS rep 1 cDNA; Lane 
7: BHIS rep 1 -RT; Lane 8: FW rep 2 cDNA; Lane 9: FW rep 2 -RT; Lane 10: PBS 
rep 2 cDNA; Lane 11: PBS rep 2 -RT. (B) Lane 1: 100 bp molecular weight marker. 
Lane 2: BHIS rep 2 cDNA; Lane 3: BHIS rep 2 -RT; Lane 4: FW rep 3 cDNA; Lane 
5: FW rep 3 -RT; Lane 6: PBS rep 3 cDNA; Lane 7: PBS rep 3 -RT; Lane 8: BHIS 
rep 3 cDNA; Lane 9: BHIS rep 3 -RT; Lane 10: gDNA; Lane 11: No template control. 
 
3.3.4 Primer validation 
Primers were designed using Primer 3 Plus software (Table 2.1 and 2.3) as described 
in Chapter 2 and validated by PCR using genomic DNA from C. difficile 630 (Figure 
3.5 a and b). Validation of the primer sets shows that the primers are able to bind to 
the template DNA and produce an amplicon of the expected size when visualised by 













Figure 3.5a: Gel electrophoresis image of a selection of primers validated by PCR 
with Clostridioides difficile 630 genomic DNA. Lane 1: 100 bp molecular weight 
marker. Lane 2: scdf2295.1; Lane 3: scdf3815.1; Lane 4: scdf1763.1; Lane 5: 




Figure 3.5b: Gel electrophoresis image of a selection of primers validated by PCR 
with Clostridioides difficile 630 genomic DNA. Lane 1: 100 bp molecular weight 
marker. Lane 2: fliC; Lane 3: fliD; Lane 4: tig; Lane 5: grpE; Lane 6: tcdA; Lane 7: 
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3.3.5 Reference gene selection and optimisation 
In order to ensure the accuracy of subsequent RT-qPCR analysis it was determined 
that a number of reference genes would be tested and the most efficient three would 
be chosen for all further qPCR analysis. Metcalf et al. (2010) previously investigated 
the use of eight reference genes in qPCR experiments within a number of 
Clostridioides difficile ribotypes. I decided to assess seven (adK, rpsJ, rho, tpi, gyrA, 
rpoA and gluD) of these reference genes for stability within my C. difficile cDNA 
samples. Validation of the primer sets was initially carried out by end-point PCR 
(Figure 3.6) and from this, five (adK, rpsJ, tpi, gyrA, and gluD) were selected for 
further analysis. Standard curves were carried out and from the data obtained, in 
addition to the use of BestKeeper software (Table 3.2), it was determined that the three 





Figure 3.6: Gel electrophoresis image of reference gene primer validation by PCR 
with Clostridioides difficile 630 genomic DNA. Lane 1: 100 bp molecular weight 
marker. Lane 2: adK; Lane 3: rpsJ; Lane 4: rho; Lane 5: tpi; Lane 6: gyrA; Lane 7: 
rpoA; Lane 8: gluD; Lane 9: tpi positive control; Lane 10: tpi no template control.  







Table 3.2: Analysis of reference genes using BestKeeper software. A standard 
deviation of < 1 suggests the reference gene is stable enough to be used in downstream 
RT-qPCR analysis.  
 
 Error Efficiency Slope Cq 
(GEOMEAN) 
SD (±) 
tpi 0.0487 1.905 -3.572 25.44 1.13 
adK 0.0437 1.941 -3.471 24.46 0.60 
gyrA 0.0542 1.998 -3.327 21.81 0.29 
rpsJ 0.0250 1.903 -3.580 19.85 0.47 
gluD 0.0582 2.028 -3.256 19.39 1.16 
 
 
3.3.6 RT-qPCR optimisation   
A robust set of guidelines have been developed by Bustin et al. (2009) these are known 
as the MIQE guidelines (Minimum Information for Publication of Quantitative Real-
Time PCR Experiments). The purpose of this is to ensure the quality and integrity of 
published RT-qPCR data in the literature. In order to comply with these guidelines 
researchers must publish specific information in relation to their experiments such as 
nucleic acid extraction method and quality, detailed RT-qPCR protocol and data 
analysis method. I can confirm that these guidelines have been adhered to as far as 





To evaluate the performance of a primer set and thereby ensure the quality of the RT-
qPCR data produced was of a high enough standard for publication the standard curves 
produced for each gene were assessed using the following criteria: Error: < 0.2; 
Efficiency: 1.8 to 2.1; Slope: -3.6 to -3.1. Only once these criteria had been met were 
the standard curves used in further RT-qPCR analysis. Table 3.3 shows the standard 
curve data produced for genes studied within this chapter and shows that all values fall 
within the specified parameters. Figures 3.7a, b and c show representative images of 
the output obtained for a single gene from a typical RT-qPCR experiment.  
 
Table 3.3: Standard curve data for all genes studied by RT-qPCR in this chapter. 
 Error Efficiency Slope Y-intercept 
adK 0.0437 1.941 -3.471 23.35 
gyrA 0.0542 1.998 -3.327 20.08 
rpsJ 0.0250 1.903 -3.580 16.41 
groEL 0.1520 2.073 -3.159 18.15 
groES 0.0367 2.005 -3.309 15.80 
fliC 0.1270 2.079 -3.146 18.73 
fliD 0.0753 1.896 -3.599 21.77 
tcdA 0.0373 1.984 -3.360 23.04 
spoVB 0.0406 2.006 -3.308 28.62 
spoIIIAC 0.0458  1.903  -3.580  25.50  






Figure 3.7a: RT-qPCR amplification curve for the reference gene rpsJ using 5-fold 
dilutions of pooled cDNA as template. 
 
 
Figure 3.7b: RT-qPCR standard curve for reference gene rpsJ using 5-fold dilutions 














Figure 3.7c: RT-qPCR melting curve for reference gene rpsJ amplified from 5-fold 
dilutions of pooled cDNA template. 
 
 
3.3.7 The presence of FW during growth results in modulation of the 
transcriptome 
RNA sequencing found 1218 C. difficile 630 transcripts differentially expressed (DE) 
(padj < 0.05, fold–change (FC) > 1.5) from growth of the organism in the presence of 
faecal water with 642 (53%) being upregulated and 576 (47%) being downregulated. 
The highest number of DE genes were categorised as “Similar to unknown proteins” 
(17.16%),“Transport binding proteins and lipoproteins” (14.94%), Metabolism of 
amino acids and related molecules” (6.81%), “Transposon and IS function” (5.91%), 
“Specific metabolic pathways” (5.67%), “Regulation of RNA synthesis” (5.67%) and 




RNAseq data validated these results. Good correlation (R2 = 0.95)  is seen between the 
two data sets (Figure 3.9) when applied to a number of motility and sporulation genes. 
 
 
Figure 3.8: Functional categorisation of differentially expressed transcripts in the 








Figure 3.9: Comparison of RT-qPCR and RNAseq data for selected Clostridioides 
difficile 630 genes. For each individual gene, expressional changes determined by 
RNAseq (up-hatched columns) and by RT-qPCR (down-hatched columns) are shown 
relative to the BHIS control, and show good correlation between the two datasets 
(R2=0.95). rpsJ, gyrA and adk were used as reference genes. 
 
 
It was found that a slightly larger proportion of the 1218 DE genes showed increased 
expression in FW media apart from those genes in the categories of ‘motility’, ‘phage-
related functions’, ‘metabolism of co-factors’, ‘transport binding’ and ‘genes 
associated with specific pathways’ (Figure 3.10). The categories where the most 
significant changes in the transcriptome were seen included ‘sporulation’, ‘motility’ 






Figure 3.10: Proportion of differentially expressed genes in the Clostridioides difficile 630 faecal water transcriptome. Blue – up regulated; 






Figure 3.11: Magnitude of maximum fold-change in expression of genes within selected functional categories. Transport, sporulation and 
conserved hypothetical protein encoding genes exhibited noticeably larger changes in expression in the faecal water exposed Clostridioides 




More than 100-fold increase in expression was observed for nine sporulation-
associated genes. The largest increase in expression of 445-fold was seen in CD1065, 
which encodes a 146 amino acid ‘conserved hypothetical protein’. Three genes 
encoding an ATP binding cassette (ABC) transporter operon (CD0873-0875) showed 
the greatest decreases in expression (> 100-fold).  The categories with the largest fold-
changes in expression were transport binding proteins and lipoproteins (up to 270-
fold),  sporulation (up to 300-fold), and genes encoding hypothetical proteins (up to 
445-fold). Fold-changes of < 20 were observed for genes associated with RNA 
metabolism, specific metabolic pathways, protein modification, adaptation to atypical 
conditions and miscellaneous categorised genes. Amongst the genes that showed the 
least change were those involved with metabolism of sulphur, lipids, and coenzymes 
(Figure 3.11), suggesting that these significant metabolic pathways were reasonably 
unaffected by the presence of FW.  
 
3.3.8 Sporulation 
In an attempt to further support the sporulation changes observed from the RNAseq 
and RT-qPCR data, spores where stained and counted in samples taken each hour 
throughout the growth cycle (10 fields of view per slide). Unfortunately, this did not 
correlate well with the transcriptomic data as no significant changes were seen (Figure 
3.12). It was noted that the error bars on Figure 3.12 were unusually large, this may be 
due to insufficient sample volume or inadequate mixing of sample prior to pipetting 
onto the glass slide. To avoid this in future I would increase the volume of sample and 
pipette to mix thoroughly to minimise clumping of spores before adding to slide. There 








Figure 3.12: No. of spores in Clostridioides difficile 630 grown in BHIS containing 
50% faecal water and in BHIS containing 50% PBS. Samples collected from growth 
curves shown in Figure 3.1 were stained using malachite green and 10 fields of view 
were analysed per sample. The data presented are the means of 3 biologically 
independent experiments and error bars represent standard deviation of the mean. 
Anova showed no significant change. 
 
3.3.9 Cell length 
It was found that bacterial cell length increased by almost 70 % at 6 h in FW media, 
with an average cell length of 4.3 µm versus 3.3 µm in the control media (p < 0.05) 
(Figure 3.13), this was despite the growth rate remaining unchanged between media 
types as seen in Figure 3.1.  
 




























Figure 3.13: Cell length of C. difficile 630 grown in BHIS/faecal water (50/50v) and 
BHIS/PBS (50/50v). Samples from growth curves shown in Figure 3.1 were Gram’s 
stained by standard methods and a total of 100 cells were measured per sample.  The 
data presented are the means of 3 biologically independent experiments and error bars 






3.4.1 RNA extraction and QC 
Reliable gene expression studies require high quality RNA but due to the Gram-
positive nature of C. difficile it can be difficult to extract RNA that is of a quantity and 
standard suitable for downstream applications such as RNA sequencing, cDNA 
synthesis, RT-qPCR and Northern blotting. The thick cell wall of Gram-positive 
organisms can make it difficult for many chemical lysis methods to penetrate, resulting 
in low yield (Nuyts et al., 2001). Over-vigorous mechanical lysis on the other hand 
can lead to shearing and loss of genetic material resulting in a low RNA integrity 
number (RIN) and/or poor purity values due to residual contaminants (Metcalf and 
Weese, 2012). We were able to extract not only high yields but also good quality RNA 
by optimising a commercially available RNA extraction kit (RNeasy® Mini kit, 
Qiagen, UK); this has resulted in the establishment of an effective and straightforward 
approach for the isolation of high quality RNA from C. difficile 630.  
 
3.4.2 RT-qPCR and reference gene optimisation 
It is widely accepted that RT-qPCR is one the most reliable and efficient methods for 
quantifying the level of nucleic acid expression within a sample (Bustin, 2000). The 
MIQE guidelines were developed in 2009 by Bustin et al. as a means of standardising 
RT-qPCR experiments and the accurate publication of the results obtained. In addition 
to high quality RNA as previously discussed the use of suitable stable reference genes 
forms a main part of the guidelines due to importance of precise normalisation of 
relative gene expression levels which allows consistent interpretation of RT-qPCR 




publication of a study purporting to show a link between autism and the measles, 
mumps and rubella (MMR) vaccine (Wakefield et al., 1998), the article was ultimately 
retracted due to the discovery of inaccurate qPCR data, but not before impacting 
greatly on worldwide uptake of the vaccine, putting many hundreds of thousands of 
vulnerable children at risk. The paper stated that the measles virus (MeV) had been 
detected in the intestine of children that had been diagnosed with autism, however no 
RT-qPCR data was included to support this claim or allow these results to be 
reproduced independently. In addition to this, there was obvious signs of 
contamination within the negative controls which was ignored. Furthermore, there was 
no mention of the quality of the RNA being analysed; this would be essential 
information in order to assess the legitimacy of the results. Only a single reference 
gene was used and no standard curve data was made available. In all, the resultant 
qPCR data analysis was deemed wholly unreliable (Bustin, 2013).  
 
The work carried out by Metcalfe et al. (2010) into the use of reference genes within 
C. difficle qPCR allowed testing of a number of reference genes for suitability with 
my samples. This has led to the development of a trio of reference genes (adK, rpsJ 
and gyrA) that can be used in future RT-qPCR analysis of C. difficile 630 experiments 
whilst safe in the knowledge that accurate normalisation is being achieved.  
 
3.4.3 Sporulation  
It is known that in Bacillus subtilis sporulation is a tightly controlled process involving 




activated at highly specific stages of the sporulation process (Underwood et al., 2009; 
Al-Hinai et al., 2014;  Abt et al., 2016). Browne et al. (2016) have recently shown 
extensive sporulation capability within the human gut microbiota, we therefore 
hypothesised that FW would induce sporulation in C. difficile.  We found that 
sporulation associated genes were amongst the most differentially expressed in the FW 
grown samples, with up to 300-fold increases.  From 67 sporulation associated genes 
that were differentially expressed in the sequencing data, there were just eight down-
regulated in the FW grown cells, these included CD2273 encoding a ‘putative 
sporulation integral membrane protein’ which may be under the control of σE, and 
CD3669 encoding a ‘putative exported protein’ which is part of the mature spore 
proteome.  
 
Nineteen of the 59 genes remaining were upregulated by more than 50-fold – this 
strongly suggests that FW is an extremely powerful inducer of sporulation in C. 
difficile 630. Sporulation in C. difficile has been extensively studied which has allowed 
the genes under the control of the master regulator Spo0A (CD1214 - increased by 2.5-
fold) to be further characterised, thereby facilitating the identification of possible 
connections between sporulation and other phenotypes (Lawley et al., 2009; Pettit et 
al., 2014; Saujet et al., 2014; Browne et al., 2016).  A sigma factor cascade is initiated 
by phosphorylation of the Spo0A protein, this impacts on the expression of the sigma 
factors σE (CD2643, 23-fold up), σG (CD2642, 40-fold up), σF (CD0772, 9-fold up) 
and σK (CD1498, 1.8-fold down) within both the mother cell and forespore, and 
controls expression of early (stage II and III) and late (stage V and VI) sporulation 




sections during sporulation due to the development of a septum – the smaller section 
(the forespore) becomes the spore and the larger section prepares the forespore for 
dormancy (Abt et al., 2016).  
 
Thereby, our data would suggest that the FW grown C. difficile 630 cells, at the point 
in which they were collected were physiologically at stage III of sporulation, this is 
the stage at which engulfment of the forespore has occurred, but before cortex 
formation. This is supported by previous studies into the identification and analysis of 
sporulation-related genes (Pettit et al., 2014; Browne et al., 2016). This correlates with 
the expression of the spoIIIAA–spoIIAH operon (all > 50-fold up), in addition to 
spoIIIJ (oxaA1, 1.6-fold up), spoIIID (56-fold up) and sigG (40-fold up) which were 
all significantly up-regulated in the FW grown samples. The sigma factor with the 
highest increase in expression was σE at 23-fold up in the FW samples. As the protein 
that σE produces is known to exert its effects on a number of genes present within the 
clostridial sporulation cascade, it was of note that there was an increase in expression 
of σE controlled genes including spoIIID, spoIVA (57-fold increase), spoVD (29-fold 
increase), cspBA (22-fold increase) and cspC (2.2-fold increase) within the RNAseq 
dataset (Pettit et al., 2014; Abt et al., 2016). In addition to this, there was an increase 
in expression of genes known to encode spore coat proteins including CotE (CD1433) 
which was 29-fold up in our data, this is significant as the chitinase and peroxiredoxin 
properties of CotE are known to facilitate pathogenesis by instigating the breakdown 






Edwards et al. (2014) have indicated that a reduction in the expression of oppABC 
(CD0853-855) which encodes an oligopeptide transporter, contributes to earlier 
expression of sporulation-associated genes, this is in keeping with our data where 
oppABC expression was 50% lower in FW and therefore consistent with other 
indications of FW induced changes in the C. difficile transcriptome within our data. It 
can therefore be suggested that the data collected shows that cells grown in FW media 
are sporulating more rapidly than those grown in BHIS media. These observations 
have strong implications for pathogenesis of C. difficile especially as spores are the 
infectious, transmissible form of the organism, and consistent with the observations of 
other studies on the extent of sporulation of microbiota within the gut (Browne et al., 
2016).  
 
3.4.4 Transport systems 
Transporter gene expression underwent considerable modulation within the FW grown 
cells, this is in contrast to previous work which showed that phosphotransferase (PTS) 
sugar transport systems were mostly unaffected by heat-stress (Ternan et al., 2014). 
The PTS consists of two main components - enzyme I (EI), and the histidine phosphor-
carrier protein (HPr) and is the key bacterial carbohydrate assimilation system for 
hexoses, hexitols and disaccharides in the cell membrane. Our dataset shows an 
increase of 1.58-fold in the  expression of the gene encoding the EI element (CD2755) 
which is a critical component of all phosphotransferase systems in the cell. However, 
the gene HPr kinase/phosphorylase (CD3409) was 1.8-fold down, this gene is known 
to phosphorylate the cytoplasmic phosphocarrier protein Hpr at Ser42 and leads to 




2016). In addition to these findings, the genes bglF (CD0388) which encodes the 
IIABC component of the PTS system for uptake of beta-glucosides was up-regulated 
as well as the downstream gene bglA (CD0389) encoding 6-phospho-beta-
glucosidase, this may be due to the increased presence of glucoside substrates in the 
FW media compared to the BHIS control media (Williamson and Clifford, 2017). 
Furthermore, the sortbitol specific component srlEa (CD0765), the fructose specific 
IIABC component, fruABC (CD2269), and the genes encoding the IIA (CD2512) and 
IIB (CD2510) components of the glucose PTS transport system were both found to be 
increased in the FW media. In addition to this, the IIC (CD3277) and IID (CD3276) 
components of the mannose/fructose/sorbose transport system were up by 4 and 6.6-
fold, respectively. However, the data shows that the genes within the xyl and xyn 
operons (CD3064-CD3070) which are PTS system components and involved in the 
uptake of xylosides were decreased in the FW media, whereas xylR (CD3066) a 
transcriptional regulator and xylose repressor which works to lower expression of 
genes for uptake and metabolism of xylose showed increased expression in FW. It 
could be suggested that these observations are the organisms attempt to adapt and 
respond to the increase in carbon sources and other diet derived metabolites that are 
present in the FW media. The PTS is also a signalling mechanism which researchers 
have been able to connect to chemotaxis and regulatory capabilities related to C, N 
and P metabolism as well as the virulence of C. difficile (Antunes et al., 2011; 
Deutscher et al., 2014).  The intricate relationship between a number of cellular 
processes such as carbon catabolite repression, quorum sensing, sugar transport and 
amino acid metabolism has been shown to regulate toxin production, we know for 
example that butyrate stimulates toxin synthesis however in the FW grown samples 




to butyrate (Martin-Verstraete et al., 2016). This is consistent with the decreased 
expression of tcdA (CD0663) by 4-fold in FW media and suggests a lowered affinity 
for butyrate production within the gut environment.  
 
We also noted that a number of genes encoding ABC transporters were DE in FW 
media, this included many involved in the transport of vitamins, amino acids, sugar 
phosphates, oligopeptides as well as transporters linked to multidrug efflux 
mechanisms (Suárez et al., 2013). The gene with the lowest expression at 270-fold 
down in FW was an ABC transporter ‘substrate-binding lipoprotein’ (CD0873), which 
acts as an adhesin that allows C. difficile to bind to Caco-2 cells (Kovacs-Simon et al., 
2014). Therefore, we could hypothesis that there is reduced binding to epithelial cells 
at the point of cell collection, in addition to the reduced motility and increased 
sporulation, and thereby suggest that this physiological condition could enable 
removal of the organism from the infected host. The data also showed increased 
expression of the lantibiotic / multidrug ABC transporters CD0161, CD1349, CD1350 
CD2210, CD2211. C. difficile as well as other gut pathogens encounter many innate 
host defences such as cationic antimicrobial peptides (CAMPs) produced by both host 
and native microbiota (Deutscher et al., 2014; Suárez et al., 2013). Previous research 
has shown that the proteins cprA (ATP–binding protein) and cprB (permease) encoded 
by CD1349 and CD1350 respectively are involved in resistance to CAMPs (McBride 
and Sonenshein, 2011). This is consistent with our initial hypothesis that increased 
levels of antimicrobial peptides present in FW lead to increased expression of this 




are more than likely as a result of the presence of FW as there was very little change 
in expression of the classical stress-response genes.  
 
3.4.5 Flagella, motility and chemotaxis 
Flagella are molecular apparatus with the ability to self-assemble, their synthesis is a 
tightly controlled process with a highly ordered control of gene expression ensuring 
the production of later-stage parts is inhibited until the assembly of earlier parts is 
finished. Flagellin (FliC) for example is only expressed after the basal body and motor 
machinery are completed. In combination with type-IV pili they are heavily involved 
in the  pathogenesis of a number of enteropathogens (Pallen and Matzke, 2006; 
Deligianni et al., 2010; Dingle et al., 2011; Evans et al., 2014; Baker, 2016). Our data 
showed that genes located in the F3 loci (CD0245-CD0271), including those encoding 
constituents of the basal body, motor, hook and rod where 1.5 to 2-fold down-regulated 
in the FW media. Similarly, the genes in the F1 locus (CD0226-CD0240) were down-
regulated by 2 to 5.7-fold – this could be due to a reduced requirement for these 
proteins until following construction of the basal body. Also, FliC (CD0239), FlgN 
(CD0230) and genes in the interflagellar F2 locus (CD0240-CD0244) were also down 
by between 3 and 5.7-fold. Thus, flagellar operon gene expression and therefore 
motility of C. difficile, decreases in FW alongside increased expression of sporulation 
genes. Dingle et al. (2011) found that a C. difficile fliC mutant strain showed improved 
adherence to intestinal-derived Caco-2 cells suggesting that flagella are either not 
needed for virulence or that reduction of motility is a tool utilised to increase 





Genes encoding a type IV pilin, a type–II secretion system protein, and a pilus 
assembly ATPase (CD3294-6) were up-regulated by 2-3-fold, this may indicate that 
pilus-driven motility could be of more significance in a FW environment and therefore 
at certain points of the infection cycle. It is known that flagella are involved in the 
development of intestinal lesions through the host inflammatory responses, as TLR5 
is recognised by FliC which leads to NF-κB and the MAPK signalling pathway 
activation and production of proinflammatory cytokines (Batah and Kansau, 2016). 
As these types of receptor are not present in our experimental system  the reduction in 
flagellar expression may suggest a complex relationship between a putative motility 
phenotype and an adhesion, or possibly, sporulation phenotype. It could be suggested 
that in the intestinal environment and presence of semi-solid material, as a form of 
energy conservation the cell may be propelled  by a less resource demanding structure 
such as type IV pili. 
 
3.4.6 Genes encoding conserved hypothetical proteins 
From the data obtained the greatest number of DE genes, 209 in total, were in the 
category of ‘Similar to unknown proteins’, from this category 19 were DE by more 
than 20-fold. Unfortunately none of the protein products of these genes had predicted 
signal peptides and were all predicted by SecretomeP to be non-classically secreted, 
apart from CD1726 and CD3522 (Petersen et al., 2011; Bendtsen et al., 2005).  From 
PsortB nine gene products had predicted locations in the cytoplasmic membrane with 
the remaining proteins possessing no conserved domains that might suggest their 





However, extensive literature and database searches has led to the identification of 
many to an involvement in sporulation pathways. The expression of CD2344 was the 
most reduced in the FW media of all the conserved hypothetical protein-encoding 
genes. The literature states that this gene is a putative succinate transporter involved 
gut colonisation in C. difficile (Ferreyra et al., 2014). A number of other genes in the 
succinate to butanoate fermentation pathway, which are downstream of CD2344 (in 
the same operon) such as cat1, sucD, abfD, cat2, and 4hbd were also down regulated 
in the FW media by approx. 4-fold (Karp et al., 2016). Many genes thought to be 
regulated by sporulation-associated sigma factors including CD3850 and CD1065 
(σK), CD2808 and CD2375 (σG), CD1063A-C, CD2150A and CD3522 (σE) were 
also found to be DE in FW media (Pettit et al., 2014; Saujet et al., 2014, Pishdadian et 
al., 2015). It has also been observed by Dembek (2014) that a large number of C. 
difficile spore transcripts encode proteins of unknown function, they thereby suggested 
that this was due to the difference between the transcriptional status of vegetative cells 
and that of spores.   
 
We can conclude that although FW did not affect growth rate, an increase in cell length 
was observed which can be assumed to be a prelude to sporulation. We have shown 
an acceleration in the sporulation cascade with large increases in the expression of 
sporulation associated genes, and simultaneous decreases in motility and toxin gene 
expression – a possible reflection of the relationship between FW and various 
regulatory systems, and transcription factors, many of which also showed increased 
expression in FW media. It can be assumed that C. difficile adapts well to a faecal 




signifies a new method of investigation into the adaptability and transcriptomic 
























CHAPTER 4: TRANSCRIPTOMIC ANALYSIS OF 
CLOSTRIDIOIDES DIFFICILE 630 MUTANT STRAINS 















Development of the ClosTron system by Heap et al. (2007) paved the way for the 
creation of reproducible mutants in an extensive array of clostridial species. This 
system utilises mobile group II introns, which make use of the retargeting capabilities 
of the Ll.ltrB group II intron of Lactococcus lactis to generate targeted gene 
disruptions and the insertion of an erythromycin resistance gene, ermB, that allows for 
positive selection of the resulting mutants (Kuehne et al., 2011) (Figure 4.1). Group II 
introns are retrotransposition elements that are composed of a self-catalytic intron 
RNA fragment and a multifunctional intron-encoded protein (IEP). Expression of the 
group II intron within the genome results in the formation of ribonuclear protein (RNP) 
complex between the Ll.LtrB group II-IEP (LtrA) and the transcribed intron RNA 
(Heap et al., 2007; Heap et al., 2010). Subsequent “retrohoming” is initiated through 
intron mobility and recognition of the target DNA (Zhong et al., 2003). Insertion of 
the RNA into the DNA is followed by reverse transcription to complete formation of 
the double stranded DNA resulting in disruption of the target gene (Mohr et al., 2000; 
Zhong et al., 2003). As explained in Chapter 1, an antibiotic resistance marker (ermB 
– which codes for erythromycin resistance) is incorporated into the design of the group 
II introns to allow for positive selection of mutants. ErmB is inactivated by the 
insertion of a group I intron (phage td). When the group II intron inserts successfully 
into the chromosome and is transcribed, the group I intron is able to self-splice out as 
it is now in the correct orientation to do so, thereby reactivating the erythromycin 
resistance gene and allowing for positive selection of intron-containing ClosTron 





A number of mutants have now been developed for a wide selection of genes including 
dnaK (Jain, 2010; Jain et al., 2017) and spo0A (Heap et al., 2007) both of which we 
have utilised within this chapter. Many other disruption mutants have been developed 
using ClosTron technology across a variety of clostridial species and genes. In C. 
difficile the genes encoding the flagellin subunit, FliC (Twine et al., 2009), the 
sporulation master regulator, Spo0A (Underwood et al., 2009), the cell surface protein, 
Cwp84 (Kirby et al., 2009), the cell wall protein, CwpV (Emerson et al., 2009), and 
the putative spore cortex-lytic enzyme, SleC (Burns et al., 2010) have all been 
disrupted to create mutants in order to elucidate gene function. Many other clostridial 
species have been engineered using the ClosTron system including the genes encoding 
- the neurotoxin type A, bont/A (Bradshaw et al., 2010) and the signalling protein 
AgrD in C. botulinum (Cooksley et al., 2010), the peptidoglycan hydrolase, Acp in C. 
perfringens (Camiade et al., 2010), and the putative type II restriction endonuclease, 










Figure 4.1: Schematic representation of the ClosTron mutagenesis system. The 
pMTL007C-E2 plasmid consists of the Ll.LtrB group II intron (orange hatched arrow) 
with an internal RAM conferring erythromycin resistance (green arrow), which is 
disrupted by the td group I intron (dark blue arrow). The group II intron is retargeted 
to the target gene (light blue hatched arrow), insertion of the group II intron into the 
chromosomal DNA in the correct orientation leads to disruption of this gene. Splicing 
out of the td group I intron from the ErmRAM restores a functional ermB gene 
allowing for the positive selection of mutants. Screening PCR primers are shown as 
black arrows. ErmS = erythromycin sensitive; ErmR = erythromycin resistant. 
Adapted from Heap et al., 2010. 
 
Development of the dnaK disruption mutant by Jain et al. (2017) has allowed us to 
study the effect of the deletion of this heat-shock protein (HSP) on C. difficile 630. 
HSPs are involved in homeostasis, protein folding and refolding and prevention of 
protein aggregation with the bacterial cell (Young et al., 2004; Hartl and Hayer-Hartl 
2009; Hartl et al., 2011). These functions provide the organism with an innate 
robustness protecting them from environmental perturbations and allowing them to 




DnaK protein works to ensure the correct folding of denatured proteins and newly 
synthesised polypeptide chains as they emerge from the ribosome (Popp et al., 2005). 
DnaK works alongside its co-chaperones DnaJ and GrpE; all three chaperones interact 
closely, alongside their negative regulator HrcA, to help maintain a steady state within 
the cell (Schonfeld et al., 1995). See Figure 4.2 for a graphical representation of how 
bacterial chaperones interact to ensure efficiency of protein folding within the cell 
(Calloni et al., 2012).  
 
  
Figure 4.2: The bacterial chaperones DnaK, DnaJ, GroES, GroEL alongside Trigger 
Factor (TF) interact closely with one another to ensure efficient protein folding within 
the cell (Calloni et al., 2012).  
 
A C. difficile spo0A disruption mutant was originally reported by Heap et al. 
describing application of the, then novel, ClosTron gene disruption system (Heap et 




(Deakin et al., 2012). Sporulation is a multifaceted sequence of events leading to the 
formation of metabolically inactive spores from vegetative cells (Paredes-Sabja et al., 
2005). In C. difficile and other sporulating bacteria it has been shown that Spo0A is 
the major transcription factor that functions in the initial stages of sporulation 
(Chastanet et al., 2010) (See Chapter 1, Figure 1.6 for C. difficile 630 sporulation 
cascade proposed by Pettit et al., 2014). A non-sporulating phenotype is induced from 
genetic inactivation of the spo0A gene (Heap et al., 2007; Underwood et al., 2009). In 
a number of Clostridium and Bacillus species including C. difficile it has been shown 
that Spo0A binds directly to DNA upstream of a number of early sporulation-
associated genes including spoIIAA, spoIIE, and spoIIGA (Rosenbusch et al., 2012). 
Several studies to date have also indicated that this transcriptional regulator is involved 
in the control of other processes not apparently associated with sporulation such as the 
expression of the toxins TcdA and TcdB. There is disagreement in the published 
literature, with tcdA and tcdB being reported variously as positively regulated in a 
spo0A mutant (Underwood et al., 2009), negatively regulated (Deakin et al., 2012; 
Mackin et al., 2013; Pettit et al., 2014) and unaffected by spo0A disruption 
(Rosenbusch et al., 2012). A number of contradictions thus currently exist in the 
literature regarding the role of Spo0A in toxin expression thereby warranting further 
investigation. Fourteen flagellar proteins including FliC were found to be upregulated 
at the mRNA level in the spo0A mutant by Pettit et al. (2014), who also found a 
significant decrease in glucose metabolism within the spo0A mutant and, furthermore, 
that the entire butyrate production operon was downregulated at both the mRNA and 
protein levels. Moreover, biofilm formation has been found to be decreased in C. 
difficile spo0A mutant strains grown in BHIS at 37 °C (Dawson et al., 2012; Dapa et 




As discussed in Chapter 3, FW provides a growth environment that can be considered 
as being similar to the contents of the human gut and therefore allows the identification 
of potential mechanisms by which C. difficile causes infection and disease that would 
not be observed in normal laboratory media. We have focused in this chapter on 
analysis of the expression of a number of genes involved in protein folding and cell 
homeostasis, motility, toxin expression and sporulation, as well as making 
observations of morphological changes of the mutants in response to FW by measuring 
















4.2 AIMS AND OBJECTIVES  
The aim of this chapter is to investigate the expression of key genes associated with 
motility, sporulation, toxin production and chaperone activity in four C. difficile strains 
grown in FW media. In particular, we wanted to see what effect, if any, the lack of 
dnaK and spo0A expression had on growth and gene expression when grown in a more 
physiologically-relevant environment such as our FW model. 
 
The main objectives for this chapter are: 
• Determine the effect of faecal water on the growth of the C. difficile strains 
630,  Derm, dnaK and spo0A. 
• Measure effect of faecal water on cell length in the four strains. 
• Investigate the effect of faecal water on motility, sporulation, toxin and 













4.3.1 DNA extraction from each of the four C. difficile 630 strains 
DNA was extracted from each strain, using the Fast DNA Spin Kit (Chapter 2, Section 
2.11) in order to confirm the genotype of each one by PCR. Both quality and quantity 
was measured using Nanodrop. Yields ranged from 194 to 318 ng/ul; 260/280 values 
ranged from 1.51 to 1.80 and the 260/230 values ranged from 0.60 to 0.75 (Table 4.1). 
Ideal Nanodrop values are: 260/280 – 1.8 – 2.0 and for 260/230 2.0 – 2.2. Although 
the values reported here fall outside the ideal ranges no amplification issues were 
encountered. 
 
Table 4.1: Nanodrop values for DNA extracted from each of the four strains from 
cells collected at late-log phase of growth. Two extractions were performed for each 
batch of cells collected.  
 
ng/uL 260/280 260/230 
630 (1) 306.6 1.55 0.75 
630 (2) 223.3 1.51 0.68 
Derm (1) 232.8 1.56 0.60 
Derm (2) 236.1 1.61 0.63 
dnaK (1) 259.8 1.79 0.71 
dnaK (2) 318.3 1.80 0.75 
spo0A (1) 239.4 1.68 0.64 






4.3.2 Confirmation of strain by genotyping PCR 
In order to validate the mutant and parental/wildtype strains PCR was performed using 
the extracted DNA. Genotyping PCR was carried out using the primer sets 4140/4620, 
4140/5880, 5880/7020, dnakF/dnakR spo0AF/spo0AR, EBS universal/dnaKR and 
EBS universal/spo0AR (Figures 4.4 a, b, c and d). For primers used see Chapter 2 
Table 2.2. The amplicon size expected in base pairs (bp) for each primer pair in each 
strain is outlined in Table 4.2. The primer set 4140F/4620R amplifies a 480 bp product 
specific to the erm1(B) gene and the Erm leader peptide present in all four isolates as 
expected as this section of DNA is retained in the mutant strains. The primer set 
4140F/5880R is designed to amplify a 1740 bp product representing the Erm leader 
peptide, erm1(B), and ORF3 and ORF298 in C. difficile 630 but not in C. difficile 
Derm and its derivatives. Primer set 5880F/7020R (1140 bp amplicon) specific to the 
ORF298 and erm2(B) was amplified from C. difficile 630 but again not in the C. 
difficile strains Derm, dnaK or spo0A as this section has been lost from these strains. 
This confirms the 2.4 kb deletion in Tn5398 in Derm (and derivatives) containing most 
of ORF298 and all of the erm2 (B) gene including some flanking regions as outlined 










Figure 4.3: Genomic structure of Tn5398 within the C. difficile chromosome prior to 
and following spontaneous deletion of erm2(B) gene. (A) The structure of the mobile 
genetic element Tn5398. (B) The structure of Tn5398D!"# in which Orf298, Orf3 and 
erm2(B) genes have been deleted. The directions of the arrowed boxes refer to the 
Open Reading Frames (ORFs) (Hussain et al., 2005).  
 
Primers dnaKF/dnaKR (Jain et al., 2017) were used to confirm the presence of the 
dnaK gene, and as expected they amplified a 210 bp product in all strains apart from 
the C. difficile dnaK mutant in which they amplified a 2059 bp product signifying the 
presence of the group II intron in correct position within the C. difficile 630 dnaK 
chromosome (Jain et al., 2017). To confirm the presence of the spo0A mutant strain 
the primer set spo0AF/spo0AR (Heap et al., 2007) amplified a 300 bp product in all 
of the strains apart from the spo0A mutant, where amplification with these primers 
yielded a 2300 bp product signifying, again, the insertion of the group II intron in the 






within the strain. The EBS universal primer in conjunction with the target gene reverse 
primer (either spo0A-R (500 bp) or dnaK-R (300 bp)) amplifies across the intron-exon 
junction in the antisense orientation, thereby confirming the intron is inserted within 
the target gene in the correct position (Figure 4.1; Figure 4.4c and 4.4d) (Heap et al., 
2007; Jain et al., 2017).  
 
Table 4.2: Expected amplicon size in base pairs (bp).  
 
CD630 CD630Derm CD630 dnaK CD630 spo0A 
4140/4620 480bp 480bp 480bp 480bp 












dnakF/dnakR 210 bp 210 bp 2059 bp 210 bp 







300 bp No product 
expected 
EBS 
















Figure 4.4a: Genotypic discrimination between 630 and Derm variants. Gel 
electrophoresis image of PCR amplicons generated with Clostridioides difficile 
genomic DNA from strains 630 and Derm. Lane 1: 100 bp molecular weight marker. 
Lane 2:630 + 4140F/4620R (480 bp); Lane 3: 630 + 4140F/5880R (1740 bp); Lane 
4: 630 + 5880F/7020R (1140 bp); Lane 5: negative control 4140F/4620R; Lane 6: 
Derm + 4140F/4620R (480 bp); Lane 7: Derm + 4140F/5880R (no band); Lane 8: 
Derm + 5880F/7020R (no band); Lane 9:negative control 4140F/5880R. 
 
 
Figure 4.4b: Genotypic discrimination between 630 and Derm variants. Gel 
electrophoresis image of PCR amplicons generated with Clostridioides difficile 
genomic DNA from mutant strains dnaK and spo0A. Lane 1: 100 bp molecular weight 
marker. Lane 2: dnaK mutant + 4140F/4620R (480 bp); Lane 3: dnaK mutant + 
4140F/5880R (no band); Lane 4: dnaK mutant + 5880F/7020R (no band); Lane 5: 
Negative control 5880F/7020R; Lane 6: spo0A mutant + 4140F/4620R (480 bp); 
Lane 7: spo0A mutant + 4140F/5880R (no band); Lane 8: spo0A mutant + 
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Figure 4.4c: Genotypic discrimination between 630 and Derm variants. Gel 
electrophoresis image of PCR amplicons generated with Clostridioides difficile 
genomic DNA from strains 630, Derm, dnaK mutant and spo0A mutant. Lane 1: 100 
bp molecular weight marker. Lane 2: 630 + dnaKF/dnaKR (210 bp); Lane 3: Derm + 
dnaKF/dnaKR (210 bp); Lane 4: spo0A mutant + dnaKF/dnaKR (210 bp); Lane 5: 
dnaK mutant + dnaKF/dnaKR (2059 bp); Lane 6: Negative control dnaKF/dnaKR; 
Lane 7: 630 + EBS universal/dnaKR (1000 bp); Lane 8: Derm + EBS 
universal/dnaKR (1000 bp). Lane 9: spo0A mutant + EBS universal/dnaKR (1000 bp). 
Lane 10: dnaK mutant + EBS universal/dnaKR (300 bp). Lane 11: Negative control 

















Figure 4.4d: Genotypic discrimination between 630 and Derm variants. Gel 
electrophoresis image of PCR amplicons generated with Clostridioides difficile 
genomic DNA from strains 630, Derm, dnaK mutant and spo0A mutant. Lane 1: 100 
bp molecular weight marker. Lane 2: 630 + spo0AF/spo0AR (300 bp); Lane 3: Derm 
+ spo0AF/spo0AR (300 bp); Lane 4: spo0A mutant + spo0AF/spo0AR (2000 bp); 
Lane 5: dnaK mutant + spo0AF/spo0AR (300 bp); Lane 6: Negative control 
spo0AF/spo0AR; Lane 7: 630 + EBS universal/spo0AR (no band); Lane 8: Derm + 
EBS universal/spo0AR (no band). Lane 9: spo0A mutant + EBS universal/spo0AR 
(~500 bp). Lane 10: dnaK mutant + EBS universal/spo0AR (no band). Lane 11: 
Negative control + EBS universal/spo0AR.  
 
As genotyping PCR successfully confirmed the identity of each strain, I was able to 
proceed with all subsequent work assured that the correct C. difficile strain was being 
used.  
 
4.3.3 Growth in FW media  
In order to study the growth rates of the four Clostridioides difficile strains – 630 
(wildtype), Derm (parental), dnaK (mutant) and spo0A (mutant) in a more biologically 







representative environment, the strains were grown in BHIS/faecal water (FW) (50/50 
v/v) with BHIS/PBS (50/50 v/v) as a control. Attenuance (D650 nm) was measured in 
triplicate over a time period of six to seven hours depending on strain and rate of 
growth. The growth rate constant (ƙ) and doubling time (Td) was calculated for each 
strain grown in each growth medium from attenuance values collected hourly. 
Exponential growth measurements from the linear part of the growth curve were used 
as outlined below (Neidhardt et al., 1990) (Table 4.3 and Figure 4.6). 
Formula used to calculate growth rate constant (ƙ): ƙ = (log10N – log10N0) × 
2.303/ (t-t0) 
N0 = OD650nm at time 0 h 
N = OD650nm at the time of exponential growth ending  
t = time of exponential growth ending (h) 
t0 = time at inoculation (0 h) 
Formula used to calculate doubling time (Td): Td = 0.693 / ƙ 
 
C. difficile 630 displayed a slightly quicker doubling time in the FW medium 
compared to the PBS control, 97 min and 104 min respectively; there was no 
significant difference (Anova, p-value > 0.05) between the two growth conditions at 
any timepoint in this strain (Figure 4.5a). The Derm strain exhibited the quickest 
doubling time of all four strains with times of 74 min in PBS and 85 min in FW, when 
analysed there was a significant difference in attenuance values in the FW medium at 
timepoint 5 (Figure 4.5b) (Anova, p-value < 0.05). However, this difference was not 
observed at timepoint 6 or 7 (Figure 4.5b). The dnaK mutant displayed the longest 
doubling time of all strains (139 min in PBS/452 min in FW). Attenuance values were 




with significant differences observed at timepoints 4, 5 and 6 (Figure 4.5c) (Anova, p-
value < 0.05). Doubling time in the spo0A mutant was again slower in the FW medium 
at 95 min in PBS and 160 min in FW but there was no significant difference (Anova, 
p-value > 0.05) in attenuance at any timepoint (Figure 4.5d). Overall, FW appears to 
reduce growth rate in the mutant strains but increase growth rate in the wildtype C. 




Figure 4.5a: Growth of Clostridioides difficile 630 in BHIS/faecal water (FW) (50/50 
v/v) and BHIS/PBS (50/50 v/v) media. Data presented are means of three independent 
biological replicates and error bars represent the standard deviation of the mean. 




























Figure 4.5b: Growth of Clostridioides difficile Derm in BHIS/faecal water (FW) 
(50/50 v/v) and BHIS/PBS (50/50 v/v) media. Data presented are means of three 
independent biological replicates and error bars represent the standard deviation of the 




Figure 4.5c: Growth of Clostridioides difficile spo0A in BHIS/faecal water (FW) 
(50/50 v/v) and BHIS/PBS (50/50 v/v) media. Data presented are means of three 
independent biological replicates and error bars represent the standard deviation of the 
mean. Anova showed no significant difference between the two growth conditions.  
 














































Figure 4.5d: Growth of Clostridioides difficile dnaK mutant strain in BHIS/faecal 
water (FW) (50/50 v/v) and BHIS/PBS (50/50 v/v) media. Data presented are means 
of three independent biological replicates and error bars represent the standard 
deviation of the mean. *p < 0.05, Anova, Post hoc: Bonferroni.  
 
 
Table 4.3: Mean growth rate constant, ƙ (hr-1) and the mean doubling time, Td (min) 
for all four strains determined from linear section of growth curve.  
Growth Medium 
630 Derm dnaK spo0A 
ƙ (h-1) Td(min) ƙ (h-1) Td(min) ƙ (h-1) Td(min) ƙ (h-1) Td(min) 
PBS 0.40 104 0.56 74 0.30 139 0.44 95 































Figure 4.6: Mean doubling time of the Clostridioides difficile strains 630, Derm, dnaK 




4.3.4 Cell length 
Previous research has shown that, in certain bacteria, cell length increases in response 
to stress (Justice et al., 2004; Pavlostathis et al., 2006; Justice et al., 2008; Alotaibi, 
2017; Jain et al., 2017), in addition to this it has been hypothesised that the dnaK 
mutant strain is in a permanent state of stress and displays a significantly longer cell 
morphology compared to the wildtype (Alotaibi, 2017; Jain et al., 2017). Therefore, 
in order to further characterise the effect of faecal water metabolites on each of the 
three strains, samples collected at each timepoint were visualised using microscopy 
(see Chapter 2 for microscope and software used) and the cell length measured; 100 
cells were measured per sample. We found that in the C. difficile 630 Derm strain there 
was a significant increase in cell length in the FW grown cells at T1 and T2 with an 



























length in the dnaK mutant strain was shown to be significantly increased from T2 
onwards until T7 in the FW samples (7.12, 7.66, 7.48, 7.60, 7.27 µm respectively) 
when compared to T0 (5.97 µm). In the spo0A mutant a significant increase in cell 
length was observed in the FW samples at T2 (4.85 µm) and T7 (4.92 µm) only (T0 = 
4.0 µm) (Figures 4.7a, b, c and d). This increase in length in the FW grown cells 
mirrors the results found for the wildtype C. difficile 630 strain (Chapter 3, Figure 
3.13) and shows that FW has a substantial effect on cell morphology.  
 
 
Figure 4.7a: Cell length of C. difficile 630 grown in BHIS/faecal water (50/50v), and 
BHIS/PBS (50/50v). Cells are significantly longer during log phase of growth in FW 
media. A total of 100 cells were measured per sample.  The data presented are the 
means of 3 biologically independent experiments and error bars represent standard 
deviation of the mean. *p < 0.05, Anova, Post hoc: Dunnett t (2-sided). 



























Figure 4.7b: Cell length of the parental strain Derm grown in BHIS/faecal water 
(50/50v) and BHIS/PBS (50/50v). Cells are significantly longer during early-log phase 
of growth in FW media. A total of 100 cells measured per sample. Means of 3 
independent experiments. Error bars represent standard deviation of the mean. *p < 




























Figure 4.7c: Cell length of the dnaK mutant strain grown in BHIS/faecal water 
(50/50v) and BHIS/PBS (50/50v). Cells are significantly longer from early-log phase 
onwards in the FW media. A total of 100 cells measured per sample. Means of 3 
independent experiments. Error bars represent standard deviation of the mean. *p < 
0.05, Anova, Post hoc: Dunnett t (2-sided).  
 
Figure 4.7d: Cell length of the spo0A mutant strain grown in BHIS/faecal water 
(50/50v) and BHIS/PBS (50/50v). Cells are significantly longer during early-log phase 
and late-log phase of growth in FW media. A total of 100 cells measured per sample. 
Means of 3 independent experiments. Error bars represent standard deviation of the 
mean. *p < 0.05, Anova, Post hoc: FW = Dunnett t (2-sided); PBS = Dunnett t3. 









































In order to determine whether there was any correlation between the cell length 
changes observed and sporulation within the strains, spore staining was undertaken to 
attempt to enumerate the spores present at each growth point (10 fields of view per 
sample). Figure 4.8a and b show representative spore stains from dnaK and Derm 
respectively, but following statistical analysis no significant differences were observed 
in the number of spores per field of view at any timepoint when compared to T0 
(Figures 4.9a and b). No spores were identified in mutant spo0A as expected. These 
findings again reflect those observed with C. difficile 630 (Chapter 3, Figure 3.12) 
where no significant change was observed. It was noted that the error bars on Figures 
4.9a and b were unusually large (as seen in Figure 3.12), again this may be due to 
insufficient sample volume or inadequate mixing of sample prior to pipetting onto the 
glass slide. To avoid this in future I would increase the volume of sample and pipette 







Figure 4.8: Clostridioides difficile (A) 630, (B) dnaK and (C) Derm grown in FW and harvested at T6. Endospore staining carried out with 
malachite green as described in Chapter 2. Image shows filamentous morphology of the dnaK mutant in comparison to the wildtype Derm. Scale 
bar = 10 µm. Original objective magnification of 1000 X. Nikon Eclipse E400 microscope used equipped with DS-5M-L1 Digital Sight Camera 
and NIS-Elements Basic Research 3.2 software.
Camera artefact 
Spores 






Figure 4.9a: No. of spores in C. difficile Derm grown in BHIS/faecal water (50/50v) 
and BHIS/PBS (50/50v). 10 fields of view per sample. Means of 3 independent 
experiments. Error bars represent standard deviation of the mean. Anova showed no 
significant change. 
 
Figure 4.9b: No. of spores in C. difficile dnaK mutant strain grown in BHIS/faecal 
water (50/50v) and BHIS/PBS (50/50v). 10 fields of view per sample. Means of 3 
independent experiments. Error bars represent standard deviation of the mean. FW = 
Anova – no significant change; PBS = Kruskal-Wallis – no significant change. 

















































4.4.5 Transcriptional analysis of selected genes 
Prior to RT-qPCR RNA was extracted from each of the four strains and Bioanalysis 
(Table 4.4) showed that all C. difficile 630 samples had a RIN of ³ 9, Derm ³ 9.7, 
dnaK mutant ³ 7.9 and spo0A mutant ³ 8.8. Based upon the C. difficile 630 RNAseq 
and RT-qPCR data presented earlier (Chapter 3) we know that a number of genes 
involved in motility, protein folding and toxin production were significantly altered in 
response to FW in C. difficile 630. These observations, combined with measurements 
showing significantly elongated cells in all four strains grown in FW (Figures 4.7a, b, 
c and d) led us to further investigate the effect of FW on the transcriptional status of 
the other three strains. The expression of a number of these genes was assessed by RT-
qPCR analysis of the strains C. difficile 630, Derm, dnaK mutant and spo0A mutant, 
using RNA extracted and reverse transcribed as described in Chapter 3. The molecular 
chaperones groEL and groES, motility genes fliC and fliD, and the gene encoding toxin 
A (tcdA) in C. difficile were analysed, using rpsJ, gyrA and adK as reference genes. 
From this it was found that the expressional fold change for groEL (630 – 1.5-fold 
down; Derm – 2.2-fold up; dnaK mutant – 2.8-fold up; spo0A mutant – 4.5-fold down) 
and groES (630 – 1.5-fold down; Derm – 1.9-fold up in FW; dnaK mutant – 2.4-fold 
up; spo0A mutant – 2.7-fold down) was increased by relatively similar amounts in the 
dnaK mutant and Derm in the FW grown samples, which was in contrast to the strains 
630 and spo0A mutant where both of these genes exhibited decreased expression.  
 
Motility gene expression showed the greatest variation across the three strains, with 
fliC (flagellin subunit) expression 5-fold down in 630, 58.8-fold down in Derm, 1.1-




flagellar cap protein) followed a similar pattern, being 4-fold down in 630, 37.3-fold 
down in Derm, 3.8-fold down in dnaK mutant and 38.4-fold down in spo0A mutant. 
Toxin A (tcdA) gene expression was decreased by 9.8-fold in 630, 22.4-fold in Derm, 
3.7-fold in dnaK mutant and 33.7-fold in spo0A mutant (Figure 4.10). 
 
Table 4.4: Bioanalysis of RNA extraction from Clostridioides difficile 630, Derm, 
dnaK mutant and spo0A mutant grown in BHIS containing 50% faecal water (FW), 
BHIS containing 50% PBS and standard BHIS made with deionized H2O. Three 
biological replicates were assessed for each growth condition. P=PBS; F=FW. *As the 
concentration of RNA was low in sample spo0A P2 no bioanalysis was carried in order 
to preserve enough sample for cDNA synthesis.  
RNA Sample Concentration 
(ng/µl) 
A260/280 A260/230 RIN 
630 P1  1477.6 2.19 2.38 9 
630 P2 1523.2 2.18 2.50 9.9 
630 P3 1391.6 2.18 2.41 9.8 
630 F1 1859.0 2.19 2.51 9.7 
630 F2 1643.0 2.19 2.33 9.4 
630 F3 1705.5 2.19 2.52 9.7 
Derm P1 2009.6 2.18 2.39 10 
Derm P2 1571.0 2.20 2.42 10 
Derm P3 1472.9 2.19 2.12 10 
Derm F1 1346.1 2.20 2.38 10 
Derm F2 1615.0 2.20 2.46 9.7 




dnaK P1 23.6 2.04 1.52 9 
dnaK P2 53.0 2.06 0.61 9.5 
dnaK P3 74.4 2.09 1.45 9.1 
dnaK F1 53.4 1.99 1.14 7.9 
dnaK F2 23.2 2.05 0.69 8.2 
dnaK F3 29.1 2.01 0.80 8.2 
spo0A P1 76.4 2.11 1.00 9.7 
spo0A P2* 16.0 1.99 0.23 - 
spo0A P3 84.7 2.09 0.89 9.5 
spo0A F1 177.6 2.16 1.31 8.9 
spo0A F2 125.5 2.32 1.08 8.8 
spo0A F3 222.7 2.16 1.46 9.2 
 
 
Figure 4.10: Comparison of expression of selected genes between C. difficile 630, 
Derm, dnaK mutant and spo0A mutant gown in FW media. Expressional changes 
determined by RT-qPCR are shown relative to the BHIS control. rpsJ, gyrA and adk 









































Sporulation gene expression was also investigated in Derm and the dnaK mutant as 
previous observations in C. difficile 630 (Chapter 3) of significant changes in the 
expression of a number of sporulation-associated genes in the FW grown cells led to 
the hypothesis that such changes could be a response to the presence of FW. The 
expression of a gene encoding a stage III sporulation protein (spoIIIAC) was increased 
in 630, Derm and the dnaK mutant by 161.2, 7.6-fold and 8.9-fold respectively. 
Transcript levels for spoVB, encoding a stage 5 sporulation protein, were found to be 
down in 630 by 1.1-fold, up in Derm by 1.2-fold, and down in the dnaK mutant by 3.1-
fold in the FW media. The gene cspC, encoding a germination-associated protein, was 
increased by 38.1-fold in 630, 3.6-fold in Derm and decreased by 1.1-fold in the dnaK 
mutant (Figure 4.11).  
 
 
Figure 4.11: Comparison between C. difficile 630, Derm and dnaK mutant of selected 
sporulation-associated genes. Expressional changes determined by RT-qPCR are 




































4.4 DISCUSSION  
4.4.1 Growth in FW 
We previously found that, for C. difficile 630, growth in the presence of FW did not 
affect growth rate (Chapter 3). We were therefore able to replicate this finding in this 
set of growth curves as a control measure (Figure 4.5a). However, the mutant strains 
dnaK and spo0A exhibited reduced growth rate in the faecal water compared to the 
parental Derm strain (Figures 4.5a, b, c and d). There was also much greater variation 
between biological replicates observed in the dnaK mutant grown in the BHIS media 
highlighting the variability of growth in this strain in particular. Jain et al. (2017) 
previously observed a reduction in growth rate of the dnaK mutant strain in BHIS 
media at 37 °C compared to the parental Derm and suggested that this may be due to 
a deficiency in the cellular synthesis of DNA and RNA as previously observed by 
Itikawa and Ryu (1979) in E. coli dnaK mutants. Reduced growth rates and lowered 
stress tolerance was also observed in a C. botulinum dnaK ClosTron mutant by Selby 
et al., (2011). Further reduced growth of the dnaK mutant in the FW media may 
suggest that FW creates a stressful environment for the mutant organism which is 
already lacking, we hypothesise, full ability to control cellular homeostasis and protein 
folding. Alotaibi (2017) report significantly reduced growth kinetics in a C. difficile 
dnaK mutant strain grown in the presence of p-cresol in comparison to the wild-type. 
We could therefore hypothesis that p-cresol present in the FW has a bacteriostatic 
effect on the dnaK mutant. Growth of the spo0A mutant was similar to the wildtype in 
the control media, this is in keeping with the growth characteristics seen by Deakin et 
al. (2012) and Pettit et al. (2014) where both strains displayed similar growth kinetics. 
However, reduced growth of the spo0A mutant was observed in the FW media, again 




lack of spo0A transcription initiation has wider knock-on effects not previously studied 
when the organism is exposed to FW and therefore opens the door for further 
investigation into sporulation initiation in the human intestinal environment.  
 
4.4.2 Cell length 
An increase in cell length was observed in Derm, dnaK mutant and spo0A mutant 
grown in FW media during early-log phase of growth (T2) this may reflect the initial 
increase in growth and therefore cell divison at this stage of growth. In addition to this 
we have witnessed a further increase in cell length in the FW media grown dnaK 
mutant cells from T2 onwards. It has been shown previously by Jain et al. (2017) that 
dnaK mutant cells are longer (6.85 ± 1.55 µm) in comparision to the wildtype (4.85 ± 
1.04 µm). Alotaibi (2017) also observed an increase in cell length in the dnaK mutant 
revealing an average cell length of 11.28 ± 3.6 μm compared to the wildtype C.difficile 
630 strain at 4.43 ± 1.19 μm. This increase in cell length has been suggested to result 
from defective cell division within dnaK mutant strains (McCarty and Walker, 1994; 
Schulz et al., 1995). Results reported by Sugimoto et al. (2008) found that in an E. coli 
dnaK deletion mutant, the filamentous morphology observed was linked to increases 
in the amount of GrpE, a co-chaperone of DnaK and DnaJ (dnaJK–GrpE operon), 
which negatively impacted the assembly of the DnaK chaperone system leading to 
faulty cell division through irregular FtsZ (a cytoskeleton protein that defines the plane 
of cell division (Margolin, 2005)) localisation (Sugimoto et al., 2008). GrpE 
expression has previously been shown to be increased in a C. difficile dnaK mutant 
(grown at 37 ºC) by Jain et al. (2017). Furthermore, it has been suggested previously 




response in E. coli (Justice et al., 2004). Justice et al. (2004) suggest that E. coli in 
mice bladder cells become filamentous as a defence mechanism to host immune 
responses, by helping them to evade infiltrating polymorphonuclear leukocytes. It is 
therefore possible that the dnaK mutant senses the extra threat from the FW 
components and utilises filamentation as means to escape potentially toxic compenents 
within the FW such p-cresol for example (previously shown to affect growth of the 
dnaK mutant by Alotaibi (2017)). The spo0A mutant showed an overall cell length of 
4.39 ± 0.89 µm and an increase in length at early and late-log but not at mid-log in the 
FW media, this late-log increase in cell length was not observed in cultures of the 
parental Derm strain. We could hypothesis that the cell length increases again at late-
log as this would normally be a time of heightened spore production due to the 
reduction in nutrient availability etc. (Pettit et al., 2014). As the spo0A mutant is unable 
to sporulate the cell may instead become further filamented as a survival mechanism 
as described by Justice et al. (2004; 2008). Further investigation would be required to 
elucidate the mechanism behind this late-log increase in cell length within the spo0A 
mutant. 
 
4.4.3 Molecular chaperones 
The molecular chaperones groEL and groES were found to be differentially regulated 
in the FW media across all four strains again emphasising the regulatory effect FW 
has on gene expression in C. difficile. Both 630 and the spo0A mutant showed a 
decrease in the expression of groEL (1.5 and 4.5-fold) and groES (1.5 and 2.7-fold) 
whereas the Derm and the dnaK mutant showed increased expression of both 




groEL and groES were up-regulated by up to 4-fold the dnaK mutant (Jain et al., 2017). 
Research in C. botulinum by Selby et al. (2011) found an upregulation of groEL and 
groES after heat stress at 45 °C. These molecular chaperones function to ensure proper 
folding of polypeptides into their appropriate final protein conformation within the cell 
by working together, forming the GroEL/ES chaperonin system which has been 
referred to as a “protein folding cage” (Georgescauld et al., 2014). It is widely accepted 
that GroEL is an essential component of the natural stress response within prokaryotes 
and tends to be induced during stress conditions including sporulation, high 
temperature and biofilm formation (Hennequin et al., 2001a; Arora et al., 2017). Our 
findings here are consistent with this in that the faecal environment appears to have 
induced a stress-response within the dnaK mutant organism. In addition to this, the 
lack of the master regulator of sporulation, Spo0A, within the spo0A mutant strain has 
led to a decrease in expression of the both of these chaperonins. Research in Bacillus 
subtilis, has shown that Spo0A regulates processes other than sporulation, such as 
metabolism and efflux pumps (Molle et al., 2003; Deakin et al., 2012). Prevous 
RNAseq in a C. difficile spo0A mutant strain (Pettit et al., 2014) did not find a 
significant change in the expression of groEL or groES, we can therefore hypothesise 
that our observations in the reduction in chaperonin expression here are due to the 
presence of FW and its affect on Spo0A.  
 
4.4.4 Motility 
The motility genes fliC and fliD were both down-regulated in all four strains in the FW 
media. The wildtype strain 630, dnaK mutant and Derm all displayed reduced 




protein (fliD). 630 – 5 (fliC) and 4-fold (fliD) down; dnaK mutant – 1.1 (fliC) and 3.8-
fold (fliD) down; Derm – 58.8 (fliC) and 37.3-fold down (fliD). Reduced expression of 
fliC has been reported previously Jain et al. (2017) where the expression of fliC was 
4-fold lower in the dnaK mutant. This decrease in FliC has also been observed in B. 
subtilis (Schulz et al., 1995) and E. coli (Shi et al., 1992) where dnaK inactivation led 
to non-motile phenotypes. The flagellum has been associated with virulence in C. 
difficile by encouraging adherence to epithelial cells within the colon (Tasteyre et al., 
2000; Tasteyre et al., 2001; Poutanen and Simor, 2004). However, other studies in C. 
difficile 630 have shown that mutations in fliC and fliD led to an increase in virulence 
(Dingle et al., 2011; Aubry et al., 2012; Baban et al., 2013). These inconsistencies are 
thought to be due to differences in the production of flagella between strains of C. 
difficile and the introduction of single nucleotide polymorphisms in Derm and its 
derivatives (Collery et al., 2017). The expression of the motility genes was also 
substantially downregulated in the spo0A mutant by up to 82-fold suggesting that 
motility is decreased under the FW growth conditions. Our results would strongly 
suggest that both the dnaK and spo0A genes play a role in the expression of these 
motility genes at least in the presence of faecal water. Sporulation and motility have 
been shown to be related functions within C. difficile previously as Pettit et al. (2014), 
for example, reported an increase in expression of motility-associated genes including 
fliC at the mRNA transcript level in the spo0A mutant under normal growth conditions. 
They suggest that this apparent negative regulation of motility factors could be a 
mechanism used by C. difficile to avoid detection by the host defences during 
sporulation, as FliC is immunogenic and has been shown to elicit an IgG response in 
hamsters (Bruxelle et al., 2018). We, however, find the absence of the master regulator 




the presence of FW. These observations further emphasise the complex nature of C. 
difficile and suggest that there are many factors involved in the expression of these 
important virulence factors. This work highlights the importance of further studies 
more closely aligned to the human colonic environment.  
 
4.4.5 Toxin expression 
Toxin A (tcdA) gene expression was decreased again in all of the FW grown strains of 
C. difficile. This follows RNAseq and RT-qPCR results (Chapter 3) with 630 where 
we observed a decrease in tcdA expression (by 4-fold) thought to be linked to an 
observed reduction in butyrate metabolism within the FW leading to a reduction in 
toxin stimulation. The reduction in tcdA expression in the dnaK mutant supports 
previous observations made by Alotaibi (2017) who also found a reduction of up to 4-
fold in transcript levels of this particular gene within the dnaK mutant. Furthermore, 
the significant decrease in tcdA expression in the spo0A mutant strain highlights the 
role of Spo0A in the expression of virulence factors (Ternan et al., 2018) (as discussed 
previously with regards to motility-associated gene expression). A number of previous 
studies have also suggested that toxin expression is closely related to sporulation 
(Underwood et al., 2009; Deakin et al., 2012; Mackin et al., 2013; Pettit et al., 2014; 
Edwards et al., 2016) and our results presented here further confirm this and further 
highlight the influence of FW on toxin A gene expression in this organism. This could 
be confirmed in future studies through the use of a toxin test on FW grown culture 
supernatants versus BHIS grown cultures where we would expect to see less toxin A 






Sporulation gene expression was assessed in the dnaK mutant strain versus the 630 
wildtype and Derm parental strains. The sporulation-associated gene spoIIIAC was 
upregulated in all of the strains under FW growth conditions. The 630 strain showed a 
very significant increase in this gene at 161-fold up whereas Derm and the dnaK 
mutant displayed more modest increases in expression of 7.6 and 8.9-fold, 
respectively. It could be suggested that unkown mutations introduced in the 
development of the Derm strain may be responsible for these differences. However, 
the increases in sporulation in the FW samples does follow the data found in Chapter 
3 and further confirms the role of FW in sporulation which is confirmed by the increase 
in cell length observered. SpoVB (involved in stage 5 of sporulation) was reduced 
slighly (3.1-fold) in the dnaK mutant suggesting that the dnaK mutant may reach this 
stage of sporulation at a much later attenuance than the parental strains which would 
follow the growth pattern observed in this strain. We also found that the gene cspC 
(encoding a germination-associated protein) was 2.5-fold downregulated in the FW 
grown dnaK mutant strain compared to 630 at 38.1-fold up and Derm at 3.6-fold up. 
This differential expression of the sporulation-associated genes indicates a potential 
regulatory function of the dnaK chaperone with regards to sporulation in the presence 
of FW within C. difficile. Supporting this idea, Li et al. (2010) found that the molecular 
chaperone GroEL1 had a regulatory function in sporulation in the organism 
Myxococcus xanthus – a Gram-negative predatory bacterium capable of forming 
multicellular structures during sporulation (Kroos et al., 1986). The link between 
molecular chaperones and sporulation in C. difficile could be further elucidated with a 




spores present was attempted by staining and microscopy but no significant data could 
be obtained from this.  
 
To summarise, this chapter represents the first study into how FW affects the C. 
difficile mutant strains dnaK and spo0A versus the wildtype strain 630 and parental 
strain Derm. We have shown that this growth environment, which we believe is 
physiologically more akin to the human intestine in which C. difficile causes disease, 
results in increased cell length in the mutant strains especially in dnaK. We also see 
that molecular chaperone, motility, toxin and sporulation gene expression is 
differentially expressed in the presence of FW with clear differences in the behaviour 
of the mutant strains strongly indicating not only that FW has an effect on C. difficile 
and thereby virulance and pathogenesis promoting capabilities but that the genes 
spo0A and dnaK may play important roles in the regulation of these responses. We 
have therefore provided a more realistic indication of how this organism may respond 














CHAPTER 5: ANALYSIS OF THE EXPRESSION OF 














All organisms express small RNA (sRNA) molecules, the majority of which act to 
regulate gene expression by altering the secondary structure of the mRNA transcript 
(Storz et al., 2004; Pichon and Felden, 2005). The discovery of sRNA molecules as 
important regulators of cellular activity in both eukaryotic and prokaryotic organisms 
has led to an increase in the understanding of RNA function (Garzon et al., 2009). The 
regulatory function of RNA was confirmed by Fire et al. (1998) who discovered RNA 
interference (RNAi) in the nematode worm, C. elegans. The RNAi pathway is found 
in most eukaryotic organisms as a sequence-specific gene silencing mechanism; this 
pathway involves the use of the enzyme Dicer, which cuts long sequences of double 
stranded RNA (dsRNA) into smaller pieces of RNA. These shorter sections of RNA 
alongside Argonaut proteins form the RNA-Induced Silencing Complex (RISC), 
which induces mRNA cleavage (Mack, 2007). The target dsRNA can be either 
exogenous (i.e. arising externally e.g. from infection by a virus) or endogenous (i.e. 
arising from within the cell e.g. naturally occurring long self-complementary RNA 
transcripts) (Hannon et al., 2002; Putral et al., 2006; Valencia-Sanchez et al., 2006). 
It is believed that RNAi is a cellular defence mechanism, protecting cells from viruses 
and transposons (Bagasra and Prilliman, 2004; Li et al., 2006). This discovery has led 
to the use of dsRNA as a molecular tool – synthetic dsRNA can be introduced into a 
cell in order to target a particular gene or set of genes and cause gene silencing from 
activation of the RNAi pathway (Setten et al., 2019). The synthetic dsRNA is 
complementary to the intended target, once bound to the mRNA of choice (after being 
made single-stranded by the RISC complex) the cell recognizes this dsRNA as 
abnormal and degradation occurs, thereby preventing translation of the target gene. 




tissue – by silencing a gene of interest the overall effect on the organism can be 
observed (Bernstein et al., 2001; Voorhoeve, and Agami, 2003; Setten et al., 2019).  
 
It was initially believed that no such regulatory mechanisms existed in prokaryotes 
until bacterial sRNAs were first identified over 40 years ago with the discovery of 6s 
RNA in E. coli (Vogel and Wagner, 2007; Vogel, 2009). However, it is only recently 
that their importance in the regulation of the bacterial genome and their influence in 
many cellular processes has become apparent. This insight has been gained through 
systematic genome-wide investigations, both in silico and laboratory based with the 
use of microarrays, PCR, blotting and sequencing techniques (Masse and Gottesman, 
2002; Vogel and Wagner, 2007). Bacterial sRNAs are typically between 50 and 500 
nucleotides in length and are located either within the intergenic regions (IGRs) 
(usually trans-acting) of the bacterial genome or on the antisense strand (usually cis-
acting). The majority of the sRNAs in prokaryotes are non-coding RNAs i.e. they do 
not produce their own protein product. Many of them behave as post-transcriptional 
regulators by bonding to specific targets (Mulhbacher et al., 2010; Chen et al., 2011). 
As with siRNA and miRNAs in eukaryotic organisms, the sRNA is able to either bind 
directly to protein targets in order to alter the function of the protein or they can bind 
to the mRNA transcripts to regulate gene expression by modulating translation 
initiation or target stability (Padalon-Brauch et al., 2008; Waters and Storz, 2009).  
 
There are two main types of bacterial sRNA, cis-encoded sRNAs and trans-encoded 
sRNAs (Figure 5.1). Cis-encoded sRNAs often involve antisense RNAs that overlap 




characterised by a sequence that is partially complementary to the target gene RNA, 
and which is encoded in a separate genomic location to the target gene (Cao et al., 
2010; Mraheil et al., 2010). Trans sRNAs are often facilitated by the protein Hfq, 
which was first discovered in 1968 in E. coli as an essential host factor of the RNA 
bacteriophage Qβ (where the name Hfq originates) (Franze de Fernandez et al., 1968). 
This protein works to increase the stability and fidelity of sRNAs and the interactions 
between them and their targets, leading to either negative or positive regulation of gene 
expression by modulating RNA stability or translation (Christiansen et al., 2004, 
Boudry et al., 2014). The importance of Hfq in C. difficile 630 has been highlighted 
by the creation of an Hfq-depleted (knockdown mutant) strain (Boudry et al., 2014). 
It was found that the absence of Hfq affected growth, morphology, and increased the 
organism’s sensitivity to stress alongside increased sporulation and biofilm formation. 
An example of a trans-acting sRNA that utilises Hfq is MicC, a 109 nucleotide sRNA, 
which base-pairs with ompD in S. Typhimurium causing mRNA degradation by RNase 
E (Pfeiffer et al., 2009). 





Many bacterial sRNAs behave as riboswitches, which are RNA molecules that are able 
to detect changes in cellular stimuli such as metabolite or nutrient changes. 
Riboswitches were first discovered in E. coli (Nahvi et al., 2002) but have since been 
found in plants, algae, and yeast suggesting that these molecules provide an important 
regulatory function in many living organisms (Shimizu et al., 2002; Andre et al., 2008; 
Wan et al., 2011). The binding of a metabolite to the aptamer section of a riboswitch 
results in a conformational change in neighboring mRNA molecules, this affects 
transcription by either creating a terminator or anti‐terminator stem, or translation by 
either blocking or revealing the Shine-Dalgarno sequence (ribosome binding site 
located up stream of the start codon AUG) (Figure 5.2) (Barrick and Breaker, 2007; 
Kim and Breaker, 2008). 
 
It has been shown that sRNAs are involved in stress response, iron homeostasis, outer 
membrane protein biogenesis, sugar metabolism, quorum sensing and bacterial 
virulence (Repoila et al., 2003; Ziebandt et al., 2004; Mraheil et al., 2010). Many 
riboswitches have been found to respond to the signalling molecule cyclic-di-
guanosyl-5’monophosphate (c-di-GMP) to regulate various pathogenic processes 
including, swimming and surface motility, intestinal colonization, biofilm 
development and toxin secretion by sensing specific receptors that respond by 
changing their activity or function (McKee et al., 2018). A number of the sRNAs in 
C. difficile are associated with membrane proteins that may act as antibiotic 
transporters or efflux mechanisms to facilitate antibiotic resistance, where 
microorganisms are able to actively pump toxic substances (such as antibiotics) out of 




modulator of gene expression in C. acetobutylicum where it functioned as a cis acting 
riboswitch in response to the antibiotic clindamycin. The sRNA, designated sCAC610, 
is located upstream of an ATP-binding cassette (ABC) transporter gene (CAC0528), 
both the sRNA and the target gene displayed up to 6.5-fold increases in expression 
following exposure to the clindamycin, suggesting an involvement in efflux pump 





Figure 5.2: Methods of riboswitch action. A: premature transcription termination B: 
inhibition of translation initiation. RBS = Ribosome binding site (Kim and Breaker, 
2008).  
 
The functions of a variety of sRNAs in C. difficile have been predicted previously 
(Tables 5.2 and 5.3) (Chen et al., 2011; Li et al., 2013; Soutourina et al., 2013). 




transcript changes in response to clinically relevant heat stress in C. difficile have 
shown that in some cases, transcript and proteome changes do not correlate (Jain, 
2010; Jain et al., 2011), and thus there may be finer levels of gene regulation at play. 
Small RNA molecules could be one such mechanism of fine gene regulation. 
Sequencing of the C. difficile 630 genome in 2006 (Sebaihia et al.) has made the 
identification of sRNAs much more straightforward. The first paper published that 
looked at sRNAs in C. difficile was Chen et al. in 2011. This study found that the 
number of sRNAs in the genomes of pathogenic Clostridia is greater than that of non-
pathogenic Clostridia. According to this study C. difficile contains the greatest number 
of individual sRNAs of all Clostridia they investigated, 264 in total. The development 
of the Bacterial Small RNA Database (BSRD) 
(http://kwanlab.bio.cuhk.edu.hk/BSRD) in 2013 provided a central repository of 
sRNAs from Gram-positive organisms (both predicted and experimentally verified) 
and allowed other researchers to design primers for a small number of these sRNAs to 
study within C. difficile (Li et al., 2013). Later in 2013, Soutourina et al. published 
their work on sRNAs in C. difficile 630, in which they identified over 250 sRNAs by 
RNAseq; further investigation found growth phase dependent expression of a number 
of sRNAs in addition to evidence of a regulatory role in motility and biofilm control 
for 16 c-di-GMP-associated riboswitches (Soutourina et al., 2013). Soutourina et al. 
(2013) also carried out transcription start site (TSS) analysis which we were able to 
utilise in our RNAseq experiments to identity sRNAs in our samples.  
 
We hypothesise that within the ever-changing gut environment, more precise gene 




stress response (Jain et al., 2011; Ternan, 2013; Ternan et al., 2018). There is still 
much to learn of sRNA activity in C. difficile, highlighting the importance of further 
investigation into how these regulatory RNA factors affect the behaviour of this 
pathogenic organism. It is especially important to investigate these regulatory RNAs 
in the presence of faecal water as this allows the replication of a more biologically 
relevant environment, the type of environment in which C. difficile is pathogenic and 

















5.2 AIMS AND OBJECTIVES 
The aim of this chapter is to investigate the expression of sRNAs in Clostridioides 
difficile 630 through the use of RNAseq and RT-qPCR techniques in order to provide 
a greater insight into how these molecules exert their regulatory abilities within this 
pathogen, and the wider implications this has on the organism.   
 
The main objectives for this chapter are: 
• Design and validate primers for use in RT-qPCR analysis of sRNAs.  
• Establish how or if sRNA expression levels differ throughout growth. 
• Compare sRNA expression levels in C. difficile 630 under normal growth 
media and in faecal water by RT-qPCR and RNA sequencing. 
• Attempt to elucidate links between sRNA and gene expression to gain insight 













5.3.1 Growth of Clostridioides difficile 630 
In order to study the growth of C. difficile strain 630 in a more biologically realistic 
environment, the organism was grown in three separate media i.e. BHIS, BHIS/faecal 
water (FW) (50/50 v/v), BHIS/PBS (50/50 v/v) as outlined in Chapter 2.2. Attenuance 
(D650 nm) was measured in triplicate over a time period of seven hours. Statistical 
analysis showed that the presence of FW in the media was not detrimental to growth 
of C. difficile strain 630 over this period of time (Figure 5.3).   
 
 
Figure 5.3: Growth (D650 nm) of Clostridioides difficile strain 630 in BHIS 
containing 50% faecal water, BHIS containing 50% PBS, and standard BHIS made 
with deionised H2O. Data presented are means of three independent biological 
replicates and error bars represent the standard deviation of the mean. 
 
 





















5.3.2 sRNA primer validation 
Primers were designed for C. difficile sRNAs chosen from the Bacterial Small RNA 
Database (BSRD) (Li et al., 2013), or from Soutourina et al. (2013) based on our own 
RNA sequencing dataset where we saw differential expression in FW (Chapter 3). The 
sRNAs selected are shown in Table 5.2. It was determined that in order to optimise 
our chances of accurate amplification, primers would be designed for the ten largest 
sRNAs in the BSRD. The presence of these was subsequently validated by PCR 
amplification (Figures 5.4a and b). In addition, six sRNAs were selected from the RNA 




Figure 5.4a: PCR validation of sRNA primers with C. difficile 630 genomic DNA. 
Lane 1: 100 bp molecular weight marker; Lane 2: tpi (CD3172); Lane 3: tpi 
(CD3172) no template control; Lane 4: scdf3688.1; Lane 5: scdf3148.1; Lane 6: 













Figure 5.4b:  PCR validation of sRNA primers with C. difficile 630 genomic DNA. 
Lane 1: 100 bp molecular weight marker; Lane 2: scdf2056.1; Lane 3: scdf3815.1; 
Lane 4: scdf1811.1; Lane 5: scdf3115.1; Lane 6: scdf1763.1; Lane 7: scdf1153.1. 
 
 
Figure 5.5: PCR validation of sRNA primers with C. difficile 630 genomic DNA. 
Lane 1: 100 bp molecular weight marker; Lane 2: CD630_s0030; Lane 3: 
CD630_n00170; Lane 4: CD630_n00330; Lane 5: CD630_s0360; Lane 6: 
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5.3.3 Validation of sRNA primers with cDNA  
Following reverse transcription of genomic DNA (as outlined in Chapter 3), the sRNA 
primers were validated by end-point RT-PCR to ensure there was sufficient 
amplification from the cDNA template (Figures 5.6a and b).  
 
 
Figure 5.6a: RT-PCR of sRNAs from C. difficile 630 cDNA. Lane 1: 100 bp 
molecular weight marker; Lane 2: scdf3688.1; Lane 3: scdf3148.1; Lane 4: scdf21.1; 
Lane 5: scdf2295.1 – not amplified (see Figure 5.6b); Lane 6: scdf2056.1; Lane 7: 
scdf3815.1; Lane 8: scdf1811.1; Lane 9: scdf3115.1; Lane 10: scdf1763.1; Lane 11: 
scdf1153.1; Lane 12: tpi (CD3172) gDNA positive PCR control; Lane 13: tpi 
















                      
 
Figure 5.6b: RT-PCR of scdf2295.1 from C. difficile 630 cDNA. Lane 1: 100 bp 
molecular weight marker; Lane 2: scdf2295.1; Lane 3: scdf2295.1 gDNA positive 
control; Lane 4: tpi (CD3172); Lane 5: tpi (CD3172) gDNA positive control; Lane 6: 
tpi (CD3172) no template control. 
 
 
5.3.4 sRNA sequencing  
As an initial quality control measure, Sanger sequencing was performed using both 
forward and reverse primers for the sRNAs scdf1811.1 and scdf21.1 with either 
cDNA, or C. difficile 630 genomic DNA as template. Each of the eight samples 
sequenced matched to the C. difficile 630 genome within the range of 97-99% proving 
that the sRNA sequences had been amplified accurately, and from the correct location 
within the genome from cDNA and genomic DNA templates. Figure 5.7 is a 
representative example of an NCBI BLAST alignment for the sequencing product of 











Figure 5.7: NCBI sequence alignment of scdf1811.1 amplified from C. difficile 630 




5.3.5 Growth phase dependent expression of sRNAs in C. difficile 
In an effort to determine whether expression of sRNAs changed throughout growth in 
Clostridioides difficile 630, RT-qPCR was carried out (Figures 5.8a and b). RNA was 
extracted and reverse transcribed from cell pellets collected at early, mid, late and 
stationary phases of growth in BHIS broth. The reference gene (Chapter 2, Table 2.1) 
rrs (16S ribosomal RNA) was used as it was shown by Metcalf et al. (2010) to be one 
of the most stable in Clostridioides difficile gene expression studies. However, 
following analysis of several reference genes as outlined in Chapter 3, the three 
reference genes used in all further RT-qPCR experiments were adk, rpsJ and gyrA. 
The ΔΔ Ct method was used to analyse the data produced from RT-qPCR of 
scdf1811.1 (Figure 5.8a) and scdf21.1 (Figure 5.8b), this method assumes that the 
efficiency of the primers is equal to 2 (i.e. that the amount of template is doubled in 
each cycle). It was decided to further investigate the expression of these two particular 
sRNAs as they were annotated as having two different functions within the BSRD 
(scdf1811.1 as a T-box leader and scdf21.1 as a signal recognition particle (SRP). It 
was found that the expression of scdf1811.1 was more than 3 times higher during mid-
log when levels were normalised to early-log phase of growth. In contrast, scdf21.1 
expression was lowest during mid-log and more than two and a half times higher 
during the stationary phase of growth compared to early-log expression levels. These 






Figure 5.8a: Relative quantification analysis of scdf1811.1 expression in C. difficile 
630 relative to reference gene rrs using the ΔΔ Ct method normalised to early-log 
phase of growth where early-log is set to 1 and the relative expression of all other 
timepoints are a reflection of this.  
 
 
Figure 5.8b: Relative quantification analysis of scdf21.1 expression in C. difficile 630 
relative to reference gene rrs using the ΔΔ Ct method normalised to early-log phase of 
growth where early-log is set to 1 and the relative expression of all other timepoints 





5.3.6 sRNA expression levels in C. difficile cells grown in the presence of faecal 
water 
In an effort to understand how sRNA expression changes in the presence of faecal 
water, C. difficile 630 cell pellets were harvested at late-log phase of growth (as 
previously described). Late-log was chosen as the most appropriate time to collect 
biomass as this is when the highest abundance of cells can be harvested from cultures 
grown using the limited supply of faecal water available. It was decided that in order 
to obtain the most reliable RT-qPCR data, standard curves would be produced for each 
primer set and RT-qPCR analysis would be conducted using this data (method outlined 
in Chapter 2). From the standard curve data, the exact efficiency of the primers could 
















Table 5.1: Standard curve data for all genes studied by RT-qPCR in this chapter. 
 Error Efficiency Slope Y-intercept 
scdf3688.1 0.046 1.974 -3.386 9.88 
scdf3148.1 0.041 1.872 -3.671 10.48 
scdf21.1 0.033 1.963 -3.414 19.13 
scdf2295.1 0.015 2.036 -3.240 20.71 
scdf2056.1 0.041 2.066 -3.173 23.34 
scdf1811.1 0.067 2.020 -3.275 24.55 
scdf3115.1 0.007 2.104 -3.095 21.39 
CD630_s0490 0.034 1.926 -3.514 24.61 
CD630_s0030 0.089 2.030 -3.252 20.09 
CD630_n00330 0.016 1.906  -3.569  26.92 
CD630_s0360 0.024 1.944 -3.464  25.56 
 
 
The relative expression levels of the target genes i.e. sRNAs can then be determined 
from the known standards. From the initial ten sRNAs, suitable standard curves were 
produced for eight of them (Table 5.1). All data was normalised to the BHIS control 
and a combination of the reference genes adk, rpsJ and gyrA (see standard curve data 
in Chapter 3, Table 3.3) was used to calculate the fold change. The analysis showed 
that expression of three of the sRNAs scdf3688.1, scdf3115.1 and scdf1763.1 were 




sRNAs was increased as follows scdf3148.1 by 1.19, scdf21.1 by 1.4, scdf2295.1 by 
2.23, scdf2056.1 by 3.51 and scdf1811.1 by 1.48-fold (Figure 5.9). 
 
 
Figure 5.9: Fold-change of sRNAs from RT-qPCR of C. difficile 630 grown in faecal 
water and BHIS control collected at late-log phase of growth. Data is normalised to 
the reference genes adk, rpsJ and gyrA. 
 
5.3.7 Verification of RNA sequencing results with RT-qPCR 
From the RNA sequencing data obtained (Chapter 3) it was noted that 51 sRNAs (p-
value < 0.01 and fold-change > 1.43) were differentially expressed in the faecal water 
grown samples. In order to further verify these results a number of these sRNAs were 
chosen for RT-qPCR analysis. We found that direction of expression i.e. up or down, 






















































further reinforce our confidence in the RNA sequencing and RT-qPCR data obtained 
to this point.  
 
Figure 5.10: Fold change of sRNAs from C. difficile 630 grown in faecal water from 
RNA sequencing data compared against the fold change obtained from RT-qPCR. RT-
qPCR data was normalised to the reference genes adk, rpsJ and gyrA. 
 
5.3.8 Antisense sRNA and corresponding gene analysis 
The RNAseq dataset was further analysed by selecting the sRNAs that were annotated 
as antisense by Soutourina et al. (2013) thus allowing a specific gene to be assigned 
to each sRNA as the target of action of the sRNA i.e. the gene complementary to the 
antisense sRNA. Antisense sRNAs are located on the “antisense” strand opposite the 
“sense” coding strand either within the coding sequence or the 5’ or 3’ UTRs. They 


















































exert their effect - the majority of antisense RNAs are cis-acting for this reason. IGR 
located sRNAs tend to be trans-acting and require Hfq for example, we haven’t gone 
into these here as they are beyond the scope of this chapter. Small RNAs were assigned 
to genes using the start and end coordinates of each sRNA to search the C. difficile 
630 NCBI reference sequence NC_009089.1. From this, 9 antisense RNAs were 
matched to their complementary genes (Table 5.3/Figure 5.11). Of these 9, 4 showed 
decreased expression in faecal water and 5 showed increased expression. Three of the 
sRNAs had corresponding genes that had p-values of 0.09 or greater (and therefore 
outside of the cut-off value of < 0.01), therefore these 3 pairs were eliminated from 
further study. The remaining 6 sRNA/gene pairs were expressed as follows: 
CD630_n00080 and its corresponding gene fliG were both down by 3.64 and 1.67-
fold, respectively. CD630_n00090 and fliH were down by 2.37 and 1.65-fold. 
CD630_n00450 and norV were down by 2.16 and 2.18-fold. SQ2179 was down by 
3.55-fold, whereas its corresponding gene xylR was up by 1.68-fold. CD630_n01110 
and SpoIIE were both increased by 4.47 and 46.14-fold, respectively. CD630_n00650 














Figure 5.11: RNA sequencing fold change of sRNA and corresponding gene from C. 
difficile 630 grown in faecal water. All sRNAs are antisense to their corresponding 

































































Table 5.2: sRNAs from Bacterial Small RNA Database (BSRD) including related information from Soutourina et al., 2013 where available.  
 









scdf3688.1 SsrA 350 3687389 3687738 -1 CD630_s0600 tmRNA 350 3687389 3687738 
scdf3148.1 RNaseP_bact_a 335 3147911 3148245 -1 CD630_s0570 Rnase P 211 3148001 3148211 
scdf21.1 ffs 265 20129 20393 1 No match     
scdf2295.1 T-box 264 2294414 2294677 -1 CD630_s0440 T box (Trp) 279 2294385 2294663 
scdf2056.1 T-box 263 2055449 2055711 1 CD630_s0390 T box 279 2055462 2055740 
scdf3815.1 T-box 263 3814001 3814263 -1      
scdf1811.1 T-box 258 1810561 1810818 1 SQ1043     
scdf3115.1 T-box 256 3114822 3115077 -1 CD630_s0560 T box (Asn) 273 3114793 3115065 




243 1762914 1763156 


















gene in DE data 
CD630_n00080 3.64 down 312822 312924 312924 -1 Antisense CDS fliG 
flagellar motor switch 
protein 
1.67 down 
CD630_n00090 2.37 down 313159 313261 313261 -1 Antisense CDS fliH flagellar assembly 
protein 
1.65 down 
CD630_n00450 2.16 down 1355629 1355729 1355729 -1 Antisense CDS norV 











CD630_n01110 4.47 up 4081910 4082308 4081910 1 Antisense CDS spoIIE stage II sporulation 
protein 
46.14 up 










There is an abundance of literature available which confirms that small RNAs 
(sRNAs) are found in all kingdoms of life and are now acknowledged as a unique class 
of gene expression modulators. Recent efforts have focused on determining sRNA 
functions under various physiological conditions and the techniques they use to exert 
these effects (Michaux et al., 2014). One such class of sRNA is the riboswitch, which 
acts by sensing ions, metabolites, temperature and pH changes and then assuming 
alternate configurations in response to these, in order to regulate downstream activities 
such as RNA processing and stability, transcription termination and translation 
initiation (Sedlyarova et al., 2016; Mellin and Cossart, 2015). This chapter contributes 
to the current understanding of how cis-acting sRNAs, which are mostly found in the 
5’ untranslated region (UTR), 3’ UTR or coding sequence (CDS) antisense to their 
target gene, behave in Clostridioides difficile 630 and potentially contribute to 
pathogenesis in this organism.   
 
5.4.1 sRNA expression is growth phase dependent 
The small RNA scdf1811.1 in C. difficile 630 is a riboswitch type sRNA which acts 
as a T-box leader according to the BSRD (Li et al., 2013). T-box leaders are regulatory 
RNA molecules which are commonly used by Gram-positive organisms to control the 
expression of aminoacyl-tRNA synthetase genes as well as those associated with 
amino acid biosynthesis and uptake (Green et al., 2010). They work by recognising 
specific tRNAs and undergoing a conformational change upon binding, this leads to 
either initiation or inhibition at the level of transcription or translation of the 




scdf1811.1 was more than 3 times higher during mid-log phase of growth when levels 
were corrected to early-log phase. It could be suggested that this sRNA is highly 
expressed during mid-log as it may be involved in the expression of genes involved in 
the exponential growth phase of C. difficile 630 such as those involved in amino acid 
biosynthesis - aminoacyl-tRNA synthetases for example. Extensive research has been 
conducted in the model organism Bacillus subtilis into how T-box riboswitches are 
involved in gene regulation. One particular gene that has been studied is the tyrS gene, 
which is an aminoacyl-tRNA synthetase gene and encodes tyrosyl-tRNA synthetase 
(TyrTS); it has been found that this gene (and others like it) are induced by limitation 
of the specific amino acid and regulated by transcription antitermination. Transcription 
antitermination is when the RNA polymerase continues elongation of the transcript by 
ignoring the termination signal allowing transcription of the section of RNA beyond 
the terminator (Henkin et al., 1992; Putzer et al., 1992; Grundy et al., 1994). T-box 
riboswitches are able to sense which amino acids are present for the ribosome to 
translate by analysing the aminoacylation levels of tRNAs. The T box leader’s RNA 
secondary structure consists of three stem loops (I, II and III) and a pseudoknot, which 
bind to the target tRNA and subsequently undergo conformational change to either 
prevent or initiate transcription termination (Figure 5.2) (Zhang and Ferré-D'Amaré, 
2015). In the case of our data it could be that transcription antitermination is allowing 
the transcription of amino-acid biosynthesis related genes during exponential growth 
due to increased demand. Regulation of tRNA synthetase genes has been studied in E. 
coli and it was found that expression is coupled to the growth rate of the cell 
(Grunberg-Manago et al., 1996). It could be suggested from the data in this study that 
as amino acids are in high demand due to the level of protein synthesis required during 




accurate and efficient replication, which is where this particular T-box leader 
riboswitch comes in. The data presented here goes towards the understanding that 
riboswitches play a significant role in the gene expression of C. difficile 630 and in 
particular during exponential growth, when a large amount of gene regulation is likely 
to be required.  
 
In contrast, the expression of scdf21.1, which is annotated as a signal recognition 
particle (SRP) in the BSRD (Li et al., 2013), was highest during the stationary-phase 
of growth, with levels more than two and a half times early-log expression. SRPs are 
universally conserved ribonucleoproteins (protein-RNA complexes) that in 
prokaryotes recognise and bind specific proteins in order to guide them to the plasma 
membrane to ensure they find their proper cellular location (Akopian et al., 2013). The 
SRP is thought to be composed of two main parts, the fifty-four homologue (Ffh) 
protein and 4.5S RNA (the small cytoplasmic RNA, or scRNA) (Patenge et al., 2012). 
A recent study described how the 4.5S RNA, a component of the SRP, has an influence 
on virulence in the Gram-positive human pathogen Streptococcus pyogenes (cause of 
Group A strep). It was found that mutation of the 4.5S RNA gene negatively impacted 
bacterial growth, reduced virulence factor expression, and lowered virulence in a 
mouse infection model (Trevino et al., 2010). Rosch et al. (2008) reported that a 
number of virulence factors involved in host cell-pathogen interactions required the 
SRP pathway for secretion in Streptococcus pyogenes. It could be suggested that the 
increase in expression levels during stationary phase of growth in C. difficile 630 is 
associated with virulence gene expression. For example, the toxin genes tcdA, tcdB 




therefore it could be hypothesised that this particular sRNA plays a role in this type of 
gene regulation. The SRP pathway also plays a role in spore formation in B. subtilis; 
Yamane et al. (2004) found that impairment of the SRP complex pathway, by 
construction of a FtsY (SRP membrane receptor filament) mutant, resulted in a 70% 
reduction in spore formation. It is worth considering the possibility that an increase in 
this particular SRP sRNA in C. difficile 630 during stationary phase of growth is 
involved in the sporulation process which would be beginning to take place at this 
stage of growth. Further study into the relationship between SRPs and virulence in C. 
difficile 630 would be required to elucidate a potential link between the two. 
Soutourina et al. (2013) have also shown that a number of sRNAs are growth-phase 
dependent in C. difficile. They found three sRNAs with their highest expression levels 
during exponential growth and three highest during stationary phase. The work 
presented here mirrors the findings of Soutourina et al. showing that sRNAs are 
differentially expressed throughout growth in C. difficile 630.  
 
5.4.2 sRNA expression changes when exposed to faecal water enriched growth 
medium 
Preliminary investigations by RT-qPCR indicated that sRNA levels change when C. 
difficile 630 is grown in faecal water enriched growth medium. Previous results have 
shown that sporulation is increased in C. difficile 630 in the presence of faecal water, 
therefore, it is reasonable to suggest that the organism senses a change in environment 
and responds accordingly. There have been numerous studies in recent years that have 
investigated the important role of sRNAs in environmental response and survival in 




Majdalani et al., 2001; Masse and Gottesman, 2002; Lease et al., 2004; Bak et al., 
2014). From eight sRNAs initially studied, three were found to exhibit reduced 
expression in the presence of faecal water. It could be hypothesised that the 
downregulation of some sRNAs in the presence of faecal water allows the target gene 
to be expressed undisturbed, as many sRNAs are shown to act as inhibitors of 
translation by base pairing with the mRNA in the ribosome-binding site (Gottesman, 
2005). The remaining five sRNAs showed increased expression in the faecal water 
grown samples. A study by Michaux et al. in 2014 found that virulence was increased 
in Enterococcus faecalis when sRNA deletion mutant strains were used to infect larvae 
and mouse models; an sRNA homologous to the RNAII component of the toxin-
antitoxin system (induced by stress) in particular was found be heavily involved in 
virulence within this organism. In addition to this, a study by Rau et al. (2015) 
confirmed that sRNAs were involved in regulatory processes within E. coli and found 
that the majority of sRNAs upregulated under multiple chemical stress conditions were 
involved in the repression of outer membrane protein expression, possibly due to the 
organism’s physiological response seeking to reduce the entry of toxic extracellular 
molecules.  
 
Further investigation with the use of RNA sequencing confirmed that sRNA 
expression levels do change in the presence of faecal water. These results were verified 
with RT-qPCR to confirm the sequencing results, this helped to further enhance 
confidence that these changes were happening. By concentrating on a number of 
antisense sRNAs we were able to analyse the corresponding gene; this helped to assign 




tend to act on the gene that is located on the complementary strand (Thomason and 
Storz, 2010), therefore we were able to assess the expression levels of the 
complementary genes from the seq data and determine how/if the sRNA was having a 
direct effect. The sRNA CD630_n00080 and its corresponding gene fliG (encoding a 
flagellar motor switch protein) were both down by 3.64 and 1.67-fold, respectively. In 
addition to this the sRNA CD630_n00090 and the complementary gene fliH (encoding 
a flagellar assembly protein) were both down by 2.37 and 1.65-fold. The data shows 
that for both pairs the sRNA exhibits decreased expression by similar amounts to the 
gene, this may suggest a close link between the expression of the two RNAs, and that 
the corresponding sRNA normally plays a role in the expression of these two motility 
genes. As flagellar gene expression occurs in highly controlled stages (Pallen and 
Matzke, 2006) it could be said that the sRNA is not yet needed at this particular time 
and has therefore not yet been switched on. We know from our earlier work (Chapter 
3; Ternan et al., 2018) that motility gene expression is reduced in C. difficile 630 grown 
in the presence of faecal water, thereby it is fair to suggest that sRNAs may play a role 
in this. Previous work on E. coli has uncovered a link between sRNAs and motility 
gene expression (De Lay and Gottesman, 2012; Bak et al., 2015). sRNAs have been 
shown to both positively and negatively regulate the main genes responsible for 
flagellar synthesis in E. coli, flhD and flhC (De Lay and Gottesman, 2012). Soutourina 
et al. (2013) first highlighted the role of sRNAs in C. difficile motility regulation on 
discovery of a group of sRNAs that respond to the universal signaling molecule c-di-
GMP (cyclic-di-guanosyl-5’monophosphate) and that these particular sRNAs affected 





The gene norV, a putative anaerobic nitric oxide reductase flavorubredoxin is 
complementary to the antisense sRNA CD630_n00450, they were both decreased by 
2.18 and 2.16-fold in the faecal water samples. NorV has been shown to be involved 
in the metabolism of nitric oxide (NO) in E. coli cells grown anaerobically (Hutchings 
et al., 2002). Nitric oxide (NO) is a key signalling molecule in the gastrointestinal tract 
and has been shown to be involved in blood flow, smooth muscle contraction and 
relaxation as well as secretory and immunological control (Vermeiren et al., 2009). 
Research has shown that bilirubin acts as an endogenous scavenger of NO within the 
gut thereby providing a protective mechanism to the presence of reactive species 
(Mancuso et al., 2006). It could therefore be suggested that NorV as a NO detoxifying 
enzyme may be downregulated in the presence of bilirubin (within the faecal water 
milieu) as NO detoxification is no longer required by C. difficile in this particular 
growth environment (Kochar et al., 2011). 
 
The sRNA SQ2179 was decreased by 3.55-fold whereas its corresponding gene xylR 
encoding a xylose repressor was increased by 1.68-fold. Xylose is a monosaccharide 
used as a carbon and energy source by many microorganisms (Heo et al., 2008). XylR 
has been shown to positively regulate xyl genes in E. coli and Salmonella typhimurium 
and negatively regulate xyl genes in other organisms including Bacillus and 
Lactobacillus species (Heo et al., 2008). The reduction in expression of the sRNA may 
have led to an increase in expression of the xylR gene as the sRNA’s regulatory effect 
was absent. As XylR is itself involved in the regulation of xylose metabolism, it would 




that these regulatory effects may be due to an adaptive response of the organism to 
other carbon sources and additional dietary metabolites present in the faecal water. 
 
CD630_n01110 and SpoIIE (encodes stage II sporulation protein e) were both 
increased by 4.47 and 46.14-fold, respectively. We have shown previously (Chapter 
3; Ternan et al., 2018) that sporulation is massively upregulated in C. difficile 630 
grown in faecal water. We therefore hypothesis that a small regulatory RNA may play 
a role in fine tuning this increase in some way, potentially through transcription 
antitermination for example. These results show that both SpoIIE and the sRNA show 
increased expression, there is however a 10-fold difference between the two. It is well 
known that Bacillus and Clostridium organisms begin sporulating when potentially 
hostile growth conditions are sensed. The sporulation process is a tightly controlled 
sequence of events at both the transcriptional and posttranslational levels involving a 
plethora of additional regulatory factors including sigma, transcription factors as well 
as many other proteins (Al-Hinai et al., 2015). Therefore, it is reasonable to assume 
that C. difficile 630 detects the faecal water environment as it would do in the gut of a 
vulnerable patient and responds by inducing sporulation. In addition to this, the 
antisense sRNA CD630_n00650 found to be complementary to the gene CD1893 were 
both increased in the faecal water samples by 2.91 and 4.17-fold respectively. CD1893 
is a putative oligonucleotide binding regulator and has been identified as being 
regulated by Spo0A (Pettit et al., 2014) further highlighting a potential involvement 
of sRNAs in sporulation in C. difficile 630. Small RNA molecules have been found to 
be involved in sporulation previously such as the sRNA CsfG, which has been found 




particular small RNA is transcribed only during sporulation and specifically in the 
forespore (Marchais et al., 2011).  
 
This is the first investigation to show that expression levels of sRNA molecules change 
during growth in a biologically relevant growth medium i.e. faecal water and that these 
changes may in turn have significant effects on the expression of other genes 
potentially involved in virulence of the organism such as sporulation, motility etc. In 
the current era of antibiotic resistance it has never been more important to uncover 
potential therapeutic and diagnostic targets such as small RNAs. This work could be 
further expanded upon with the use of Northern blotting for confirmation of RNA 
expression and Western blotting to confirm protein abundance and also the effect of 
sRNAs on the translation of proteins from genes of interest. In addition to this, the 
development of sRNA mutants would provide a much deeper insight into the effects 




























Clostridioides difficile Infection (CDI) is a known healthcare acquired disease and 
significant source of antibiotic-associated diarrhoea (AAD) and colitis (Bartlett, 
2009). CDI is reported to be responsible for up to a third of recorded instances of AAD 
worldwide (Arriola et al., 2016). The financial burden of CDI on the UK health service 
is substantial, with a median total cost per patient of between £5631 and £8542 
(Wilcox et al., 2017). Most of the research conducted into how C. difficile causes 
disease is carried out in artificial laboratory media, limiting insight into how this 
pathogen responds to the environment in which it causes disease i.e. the large intestine. 
The overall aim of this study was to construct a faecal water model to study the 
transcriptome of C. difficile 630 in order to characterise the molecular mechanisms 
underpinning pathogenesis within the organism. We hypothesised that understanding 
how C. difficile functions in a more biologically relevant setting would uncover 
mechanisms at work that could not be determined with the use of normal laboratory 
media by developing an in-vitro model to determine growth characteristics and the 
transcriptional profile of C. difficile 630 and the mutant strains Derm, dnaK and spo0A.  
 
Chapter 3 aimed to determine which genes were significantly differentially expressed 
in the faecal water media in order to characterise the effect of FW on  C. difficile 630 
gene expression by RNAseq and RT-qPCR analysis. We therefore extracted high 
quality RNA in sufficient quantities to guarantee the reliability of downstream results. 
Optimisation of the RNA extraction protocol alongside reference gene analysis and 
adherence to the MIQE guidelines ensured that the transcriptomic data obtained was 




RNA quality and RT-qPCR experiment construction and analysis that aim to ensure 
accuracy and reliability of downstream RT-qPCR results.  
 
The work of Browne et al. (2016) showed that the human gut microbiota has extensive 
sporulation capability, this allowed us to hypothesis that sporulation associated genes 
would be upregulated in the FW media. The RNAseq results obtained confirmed this, 
with up-to 300-fold increases strongly indicating that FW is an particularly potent 
inducer of sporulation in C. difficile 630. Increased cell length was observed which we 
assume may be a prelude to sporulation. Significant modulation of transport system 
associated genes was observed in the FW samples which could be the organisms 
attempt to adapt to the increase in carbon sources and other diet-derived metabolites 
within the FW media. The lack of classical heat-stress response also confirmed that 
the changes observed are most likely due to the presence of FW and its constituents. 
The data also revealed an increase in expression of the lantibiotic / multidrug ABC 
transporters, previous research has shown that the proteins cprA and cprB are involved 
in resistance to cationic antimicrobial peptides (CAMPs) (McBride and Sonenshein, 
2011). We also found an overall reduction in motility gene expression as the flagellar 
operon was decreased in response to FW. Dingle et al. (2011) found that a C. difficile 
fliC mutant strain showed improved adherence to intestinal-derived Caco-2 cells 
suggesting that flagella are either not needed for virulence or that reduction of motility 
is a tool utilised to increase pathogenesis of the organism. It could also be suggested 
that suppression of motility occurs as a form of energy conservation in the gut 





Our observations from the RNAseq data led us to explore the expression of key genes 
associated with motility, sporulation, toxin production and chaperone activity in the 
two C. difficile mutant strains dnaK and spo0A compared to the wildtype C. difficile 
630 and the parental strain Derm. We sought to determine if faecal water had an effect 
on the growth of Derm and the dnaK and spo0A mutant strains compared to what we 
witnessed with C. difficile 630 in Chapter 3. We found that we were able to replicate 
the findings of Chapter 3 with 630 as it again grew unaffected by the presence of FW. 
The mutant strains however, displayed reduced growth rate in the FW compared to the 
parental Derm strain. Reduced growth rate in dnaK mutants has been witnessed 
previously (Jain et al., 2017) and has been attributed to a deficiency in the cellular 
synthesis of DNA and RNA (observed by Itikawa and Ryu (1979) in E. coli dnaK 
mutants). Selby et al. (2011) found reduced growth rates and lowered stress tolerance 
in a C. botulinum dnaK ClosTron mutant. Our findings indicate that the dnaK mutant 
may perceive the FW environment as stressful. In addition to the observations 
discussed the dnaK mutant also exhibits temperature sensitivity and increased 
expression of other chaperones (Jain et al., 2017) suggesting that it is, physiologically, 
in a form of permanent heat stress, thereby, making it more sensitive to additional 
stresses such as the FW environment.  
 
Reduced growth was also seen in the spo0A mutant grown in FW, highlighting a 
potential role for Spo0A in how the organism responds to the intestinal environment. 
An increase in cell length was found in both the dnaK and spo0A mutant strains in FW, 
which we hypothesise could be a possible defence mechanism employed by the 




were found to be increased in the Derm and dnaK mutant strains and reduced in 630 
and spo0A strains in FW. As GroEL is an important component of the natural stress 
response within prokaryotes (Hennequin et al., 2001a; Arora et al., 2017) our findings 
suggest that FW appears to have induced a stress-response within the dnaK mutant 
organism. We know that Spo0A regulates processes other than sporulation, such as 
metabolism and efflux pumps (Molle et al., 2003; Deakin et al., 2012), it could 
therefore be said that this increase in GroEL and GroES in the spo0A mutant suggests 
a potential regulatory role for Spo0A in chaperone expression. The expression of tcdA 
was reduced in both the dnaK and spo0A mutant strains grown in FW. Previous 
research has linked toxin expression to sporulation, where toxin production is shown 
to be reduced (Underwood et al., 2009) or increased (Deakin et al., 2012; Pettit et al., 
2014) in spo0A mutant strains. Other research has found that toxin production can be 
either increased or decreased in spo0A mutants depending on strain type (Mackin et 
al., 2013). Our results add to this knowledge and further highlight the influence of FW 
on virulence gene expression in this organism. These observations further emphasise 
the complex nature of C. difficile and suggest that there are many elements involved 
in the expression of these important virulence factors. Differences in sporulation 
associated gene expression within the dnaK mutant strain were observed with SpoVB 
and cspC reduced by up to 3-fold. We hypothesis that the dnaK mutant reaches stage 
5 of sporulation at a later stage than the wild-type and parental strains, this is in keeping 
with the reduced growth kinetics observed in this strain. This differential expression 
of the sporulation-associated genes indicates a potential regulatory function of the 
dnaK chaperone with regards to sporulation in the presence of FW within C. difficile. 
This work represents the first study into how FW affects the C. difficile mutant strains 




strongly indicating not only that FW has an effect on C. difficile and thereby virulance 
and pathogenesis promoting capabilities but that the genes spo0A and dnaK may play 
important roles in the regulation of these responses.  
 
Chapter 5 sought to investigate the expression of sRNAs in C. difficile 630 grown in 
FW through the use of RNAseq and RT-qPCR in order to provide a greater insight 
into how these molecules exert their regulatory functions within this pathogen, and the 
wider implications this has for the organism. Initial investigations found that sRNA 
expression differed throughout growth with expression of a T-box leader riboswitch 3 
times higher during mid-log compared to early-log phase. We suggest this increase 
during exponential growth may be due to the increased demand for amino acid 
biosynthesis during this phase of growth as previous work by Grunberg-Manago et al. 
(1996) found that expression of tRNA synthetase genes is linked to the growth rate of 
the cell in E. coli. We also found that a sRNA annotated as a signal recognition particle 
(SRP) was most highly expressed during stationary growth. A number of studies have 
found a link between SRPs and virulence in bacteria (Yamane et al., 2004; Rosch et 
al., 2008; Trevino et al., 2010); as spore production is active during stationary phase 
(Pettit et al., 2014) we hypothesise a potential role for this sRNA in sporulation in C. 
difficile 630. Investigation into the expression of sRNAs in C. difficile 630 grown in 
faecal water enriched growth medium showed that sRNA expression changes in 
response to the presence of FW. The expression of two sRNAs complementary to the 
motility-associated genes fliG and fliH, was found to be decreased in FW indicating a 
possible positive regulatory role for the sRNA i.e. less sRNA expression equals less 




negatively regulate the main genes responsible for flagellar synthesis in E. coli, flhD 
and flhC (De Lay and Gottesman, 2012; Bak et al., 2015) and motility, biofilm 
formation and virulence in C. difficile (Soutourina et al., 2013). As we know that 
motility gene expression is reduced in C. difficile 630 grown in the presence of faecal 
water (Chapter 3; Ternan et al., 2018) it is reasonable to suggest that sRNAs may play 
a role in this. A sRNA and its complementary gene which encodes NorV (involved in 
the metabolism of nitric oxide, NO (Hutchings et al., 2002)) were both down in FW 
suggesting a positive regulatory relationship. NO is a key signalling molecule in the 
GI tract (Vermeiren et al., 2009) and research has shown that bilirubin acts as an 
endogenous scavenger of nitrous oxide (NO) within the gut thereby providing a 
protective mechanism to the presence of reactive species (Mancuso et al., 2006). We 
have therefore suggested that NorV, as a NO detoxifying enzyme, may be 
downregulated in the presence of bilirubin (within the faecal water milieu) as NO 
detoxification is no longer required by C. difficile in this growth environment (Kochar 
et al., 2011). The gene encoding XylR (a xylose repressor) was increased whereas its 
corresponding sRNA was decreased. This reduction in expression of the sRNA may 
have led to an increase in expression of the xylR gene as the sRNA’s regulatory effect 
was absent. As XylR is involved in the regulation of xylose metabolism, it would 
suggest that this pathway is affected by the presence of faecal water possibly due to an 
adaptive response of the organism to other carbon sources and additional dietary 
metabolites within the FW. A possible regulatory role for sRNAs in sporulation within 
C. difficile 630 has also been identified where both sRNA and the gene encoding 
SpoIIE were found to be increased in FW. We know that expression of sporulation 
associated genes is increased in the FW environment from our previous work. 




(although the changes were not statistically significant) (Chapter 3; Ternan et al., 
2018) and we therefore suggest that sRNAs are involved in this process and may 
explain the discrepancy between the transcriptome and spores produced. This is the 
first investigation to show that expression levels of sRNA molecules change during 
growth in a biologically relevant growth medium and that these changes may in turn 
have significant effects on the expression of other genes potentially involved in 
virulence of the organism. With  antibiotic resistance growing it has never been more 
important to uncover potential therapeutic and diagnostic targets to ensure the ability 
to treat infectious diseases in the future. 
 
Although we have contributed significantly within this thesis to the current 
understanding of C. difficile 630 and many of the processes involved in pathogenesis, 
including motility and sporulation, we have also created many questions that we did 
not have the opportunity to pursue in this project. I believe further investigations could 
focus on the analysis of the transcriptome of the spo0A mutant strain grown in FW in 
order to further elucidate the mechanisms behind the large increase in sporulation 
found in our work in addition to further investigating the role of Spo0A beyond 
sporulation. Future studies to further elucidate the exact mechanisms behind sRNA 
regulation of genes in C. difficile could focus on the development of sRNA mutant 
strains in order to characterise the global effects of these important regulators. 
Confirmation of sRNA transcripts through Northern blotting would also add an extra 
layer of robustness in addition to the use of Western blotting to validate the protein 




In conclusion, this thesis provides a deeper understanding of how the transcriptome of 
C. difficile 630 alters in response to faecal water and suggests that important molecular 
processes are not being picked up in studies that employ basic laboratory growth 
media. The impact of the faecal water growth environment on C. difficile is clear with 
significant expressional changes observed in sporulation, motility, virulence factors 
and an important role for regulatory sRNAs in these processes. We have provided a 
more realistic indication of how this organism may respond in the presence of human 
gut constituents whilst underscoring the regulatory effect FW has on gene expression 
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